var title_f3_35_3632="Small pericardial effusion II";
var content_f3_35_3632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small pericardial effusion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 223px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The long (panel A) and short axis (panel B) two- dimensional images show a small pericardial effusion (arrows). The M-mode echocardiogram (panel C) shows the posterior wall to be separated from the pericardium (arrow).",
"    <div class=\"footnotes\">",
"     LV: left ventricle; IVS: interventricular septum.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3632=[""].join("\n");
var outline_f3_35_3632=null;
var title_f3_35_3633="Pathogenesis breast Paget";
var content_f3_35_3633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F61409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F61409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenesis of Paget disease of the breast as a consequence of the motility factor heregulin-&alpha;",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Heregulin-&alpha; messenger RNA is produced by the nipple epidermal keratinocytes, which secrete heregulin-&alpha; protein. Heregulin-&alpha; then binds to a heterodimer of HER3 and HER-2/NEU or of HER4 and HER2/NEU on Paget cells. HER1 is expressed on the membranes of some normal epidermal cells and does not appear to be involved in the pathogenesis of Paget disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schelfhout VR, Coene ED, Delaey B, et al. Pathogenesis of Paget's disease: Epidermal heregulin-alpha motility factor and the HER receptor family. J Natl Cancer Inst 2000; 92:622. Copyright &copy; 2000 Oxford University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3633=[""].join("\n");
var outline_f3_35_3633=null;
var title_f3_35_3634="Kidney anatomy PI";
var content_f3_35_3634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F80336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F80336&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Anatomy of the kidney",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 421px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the structure of a kidney. The outer portion (the cortex) contains the glomeruli. The tubules are located in the cortex and medulla. The collecting tubules form a large portion of the inner medulla (the papilla). Urine travels from the collecting tubules into the caylces, and then to the renal pelvis, ureter, and bladder.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3634=[""].join("\n");
var outline_f3_35_3634=null;
var title_f3_35_3635="Trichloroacetic acid: Patient drug information";
var content_f3_35_3635=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Trichloroacetic acid: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/39/7794?source=see_link\">",
"     see \"Trichloroacetic acid: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230857\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tri-Chlor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012559\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to get rid of warts.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to trichloroacetic acid or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012563\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012566\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012561\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696363",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Your doctor will put on the skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12142 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.211.0.116-30B47D18B6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3635=[""].join("\n");
var outline_f3_35_3635=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230857\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012559\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012558\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012563\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012564\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012566\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012561\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012568\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?7/39/7794?source=related_link\">",
"      Trichloroacetic acid: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3636="Metronidazole and nystatin: Patient drug information";
var content_f3_35_3636=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Metronidazole and nystatin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/16/30979?source=see_link\">",
"     see \"Metronidazole and nystatin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2530152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Flagystatin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014436\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692122",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat vaginal infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014435\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702520",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to metronidazole, nystatin, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696941",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug if you have belly pain, fever, or bad-smelling discharge. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect clothing and fabrics from staining.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaginal irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697954",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of urine to black or brown.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014443\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have many vaginal infections.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014438\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696219",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use vaginally.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014439\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014444\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699374",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store cream and ovules at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014445\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11503 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-83C710A96E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3636=[""].join("\n");
var outline_f3_35_3636=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530152\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014436\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014435\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014440\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014441\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014443\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014438\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014439\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014444\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014445\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?30/16/30979?source=related_link\">",
"      Metronidazole and nystatin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3637="Benzphetamine: Patient drug information";
var content_f3_35_3637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Benzphetamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/56/36741?source=see_link\">",
"     see \"Benzphetamine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F140159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Didrex&reg;;",
"     </li>",
"     <li>",
"      Regimex&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming; avoid long-term use. Use this drug as ordered by your doctor. Tell your doctor if you have a history of drug or alcohol abuse. Misuse of this drug may cause unsafe heart-related side effects. Tell your doctor if you have any heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691993",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat obesity.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701608",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to benzphetamine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Drug abuse, glaucoma, heart disease, high blood pressure, nervous problem, overactive thyroid gland, or structure problems of the heart.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698413",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often if you have heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697801",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may not be alert. Avoid driving and doing other tasks or actions until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure or a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699005",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad problems with how you act.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696213",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug early in the day to stop sleep problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11232 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-37B631BF3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3637=[""].join("\n");
var outline_f3_35_3637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F140159\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020213\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020215\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020214\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020219\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020220\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020222\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020217\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020218\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020223\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020224\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/56/36741?source=related_link\">",
"      Benzphetamine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3638="Valacyclovir: Pediatric drug information";
var content_f3_35_3638=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Valacyclovir: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"    see \"Valacyclovir: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?34/45/35540?source=see_link\">",
"    see \"Valacyclovir: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F232799\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Valtrex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F232800\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Valacyclovir&reg;;",
"     </li>",
"     <li>",
"      CO Valacyclovir;",
"     </li>",
"     <li>",
"      DOM-Valacyclovir;",
"     </li>",
"     <li>",
"      Mylan-Valacyclovir;",
"     </li>",
"     <li>",
"      PHL-Valacyclovir;",
"     </li>",
"     <li>",
"      PMS-Valacyclovir;",
"     </li>",
"     <li>",
"      PRO-Valacyclovir;",
"     </li>",
"     <li>",
"      Riva-Valacyclovir;",
"     </li>",
"     <li>",
"      Valtrex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1041673\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antiviral Agent, Oral",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1041707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"      see \"Valacyclovir: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Chickenpox, treatment (immunocompetent patients):",
"     </b>",
"     2 years to &lt;18 years: 20 mg/kg/dose 3 times daily for 5 days (maximum: 1000 mg/dose), initiate within 24 hours of rash onset",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Herpes labialis (cold sores), treatment:",
"     </b>",
"     &ge;12 years: 2000 mg every 12 hours for 1 day (2 doses), initiate at earliest symptom onset",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      HSV or VZV, prophylaxis (immunocompromised patients with normal renal function):",
"     </b>",
"     Children and Adolescents: Limited data available: 15-30 mg/kg/dose given 3 times daily have been reported in pharmacokinetic studies (maximum: 2000 mg/dose)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      HSV, treatment (immunocompetent patients):",
"     </b>",
"     3 months to 11 years: 20 mg/kg/dose twice daily (maximum: 1000 mg/dose) (Kimberlin, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      CMV prophylaxis in allogeneic HSCT recipients:",
"     </b>",
"     2000 mg 4 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Herpes labialis (cold sores):",
"     </b>",
"     2000 mg every 12 hours for 1 day, initiate at earliest symptom onset",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Herpes zoster (shingles):",
"     </b>",
"     1000 mg 3 times daily for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      HSV, VZV in cancer patients:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Prophylaxis: 500 mg 2-3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Treatment: 1000 mg 3 times daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Genital herpes:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial episode: 1000 mg twice daily for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Recurrent episode: 500 mg twice daily for 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Reduction of transmission: 500 mg once daily (source partner)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Suppressive therapy:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Immunocompetent patients: 1000 mg once daily (500 mg once daily in patients with &lt;9 recurrences/year)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     HIV-infected patients (CD4 &ge;100 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ): 500 mg twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Suppressive therapy during pregnancy: 500 mg twice daily from 36 weeks estimated gestational age until delivery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosing interval in renal impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Herpes labialis: Adolescents and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-49 mL/minute: 1000 mg every 12 hours for 2 doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 500 mg every 12 hours for 2 doses",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg as a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Herpes zoster: Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-49 mL/minute: 1000 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 1000 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genital herpes: Adolescents and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Initial episode:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     10-29 mL/minute: 1000 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;10 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Recurrent episode: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;29 mL/minute: 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Suppressive therapy: Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;29 mL/minute:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     For usual dose of 1000 mg every 24 hours, decrease dose to 500 mg every 24 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     For usual dose of 500 mg every 24 hours, decrease dose to 500 mg every 48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     HIV-infected patients: 500 mg every 24 hours",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F232774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Caplet, oral: 500 mg, 1 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valtrex&reg;: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Valtrex&reg;: 1 g [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 500 mg, 1 g",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F232759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1041713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Oral: May administer with or without food",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1041695\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 15&deg;C to 25&deg;C (59&deg;F to 77&deg;F).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1041674\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of herpes labialis (cold sores) (FDA approved in ages &ge;12 years and adults); treatment of chickenpox in immunocompetent patients (FDA approved in ages 2 to &lt;18 years); treatment of herpes zoster (shingles) in immunocompetent patients (FDA approved in adults); treatment of initial and recurrent episodes of genital herpes (FDA approved in adults); suppression of recurrent genital herpes and reduction of heterosexual transmission of genital herpes in immunocompetent patients (FDA approved in adults); has also been used for suppression of genital herpes in HIV-infected individuals; suppression and prevention of vertical transmission of recurrent genital herpes during labor and delivery; for prevention and treatment of herpes infections in both immunocompromised and immunocompetent patients",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F232826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Valtrex&reg; may be confused with Keflex&reg;, Valcyte&reg;, Zovirax&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       ValACYclovir may be confused with acyclovir, valGANciclovir, vancomycin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F232824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Depression, dizziness, fatigue, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine: Dehydration, dysmenorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal:  Abdominal pain, diarrhea, nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Neutropenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, ALT increased, AST increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Nasopharyngitis, rhinorrhea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Herpes simplex",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute hypersensitivity reactions (angioedema, anaphylaxis, dyspnea, pruritus, rash, urticaria); aggression, agitation, alopecia, anemia, aplastic anemia, ataxia, creatinine increased, coma, confusion, consciousness decreased, delirium, dysarthria, encephalopathy, erythema multiforme, facial edema, hallucinations (auditory and visual), hemolytic uremic syndrome (HUS), hepatitis, hypertension, leukocytoclastic vasculitis, leukopenia, mania, photosensitivity reaction, psychosis, renal failure, renal pain, seizure, tachycardia, thrombotic thrombocytopenic purpura (TTP), tremor, urinary precipitation, visual disturbances",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1041681\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to valacyclovir, acyclovir, or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F2984816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     CNS adverse events (eg, agitation, hallucinations, confusion, delirium, seizures, and encephalopathy) have been reported in children with and without renal dysfunction receiving doses exceeding those recommended for current renal function. Use with caution in patients with renal impairment, patients receiving concomitant nephrotoxic drugs, or inadequately hydrated patients; modify dose in patients with renal impairment.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1041682\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) has occurred in immunocompromised patients (bone marrow or renal transplant or advanced HIV disease) receiving 8 g/day.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F232768\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mycophenolate: May increase the serum concentration of Acyclovir-Valacyclovir. Acyclovir-Valacyclovir may increase the serum concentration of Mycophenolate.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tenofovir: Acyclovir-Valacyclovir may decrease the excretion of Tenofovir.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Acyclovir-Valacyclovir may enhance the CNS depressant effect of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zoster Vaccine: Acyclovir-Valacyclovir may diminish the therapeutic effect of Zoster Vaccine.  Management: When possible, discontinue antiviral agents with anti-zoster activity (i.e., acyclovir, valacyclovir, famciclovir) for at least 24 hours prior to and 14 days after receiving a live attenuated zoster vaccine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F2984817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Food does not appear to affect absorption.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F232770\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F232784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic events were not observed in animal studies. Data from a pregnancy registry has shown no increased rate of birth defects than that of the general population; however, the registry is small and use during pregnancy is only warranted if the potential benefit to the mother justifies the risk of the fetus.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1041715\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Urinalysis, BUN, serum creatinine, liver enzymes, CBC",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1041697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Valacyclovir is rapidly and nearly completely converted to acyclovir by intestinal and hepatic metabolism. Acyclovir is converted to acyclovir monophosphate by virus-specific thymidine kinase then further converted to acyclovir triphosphate by other cellular enzymes. Acyclovir triphosphate inhibits DNA synthesis and viral replication by competing with deoxyguanosine triphosphate for viral DNA polymerase and being incorporated into viral DNA.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1041699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Acyclovir is widely distributed throughout the body including brain, kidney, lungs, liver, spleen, muscle, uterus, vagina, and CSF; CSF acyclovir concentration is 50% of serum concentration; crosses the placenta; excreted into breast milk",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 13.5% to 17.9%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Valacyclovir is converted to acyclovir and L-valine by first-pass intestinal and/or hepatic metabolism; acyclovir is metabolized to a small extent by aldehyde oxidase, alcohol, and aldehyde dehydrogenase to inactive metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~42% to 64%, decreased bioavailability with higher doses in children",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Normal renal function:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Acyclovir:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children: 1.3-2.5 hours, slower clearance with increased age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Adults: 2-3.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Valacyclovir: Adults: ~30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     End-stage renal disease: Acyclovir: 14-20 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: 1.4-2.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 88% as acyclovir in the urine.",
"     <b>",
"      Note:",
"     </b>",
"     Following oral radiolabeled valacyclovir administration, 46% of the label is eliminated in feces and 47% is eliminated in urine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: 33% removed during 4-hour hemodialysis session; administer dose postdialysis",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1041719\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/45/35540?source=see_link\">",
"      see \"Valacyclovir: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Report any rash, headache, nausea, vomiting, problems with vision, behavioral changes, unusual bleeding or bruising, or blood in urine or stool.",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F6869964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nadal (2002) suggests the following dosage equivalency:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     30 mg/kg/dose 3 times/day valacyclovir corresponds to I.V. acyclovir 250 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     or 10 mg/kg/dose 3 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     20 mg/kg/dose 3 times/day valacyclovir corresponds to oral acyclovir 20 mg/kg 4-5 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Eksborg, et al (2002) suggests the following dosage equivalency: 500 mg valacyclovir equivalent to 349 mg of  I.V. acyclovir",
"    </p>",
"   </div>",
"   <div class=\"block exp drugH1Div\" id=\"F6825106\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Extemporaneous Preparations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A 50 mg/mL oral suspension may be made with caplets and either Ora-Sweet&reg; or Ora-Sweet SF&reg;. Crush eighteen 500 mg caplets in a mortar and reduce to a fine powder. Add 5 mL portions of chosen vehicle (40 mL total) and mix to a uniform paste; transfer to a 180 mL calibrated amber glass bottle, rinse mortar with 10 mL of vehicle 5 times, and add quantity of vehicle sufficient to make 180 mL. Label \"shake well\" and \"refrigerate\". Stable for 21 days refrigerated.",
"    </p>",
"    <div class=\"reference\">",
"     Fish DN, Vidaurri VA, and Deeter RG, \"Stability of Valacyclovir Hydrochloride in Extemporaneously Prepared Oral Liquids,\"",
"     <i>",
"      Am J Health Syst Pharm",
"     </i>",
"     , 1999, 56(19):1957-60.",
"     <span class=\"pubmed-id\">",
"      10554914",
"     </span>",
"    </div>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ACOG Committee on Practice Bulletins, \"ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. No. 82 June 2007. Management of Herpes in Pregnancy,\"",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2007, 109(6):1489-98.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/17569194/pubmed\" id=\"17569194\" target=\"_blank\">",
"        17569194",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Balfour HH Jr, Hokanson KM, Schacherer RM, et al, \"A Virologic Pilot Study of Valacyclovir in Infectious Mononucleosis,\"",
"      <i>",
"       J Clin Virol",
"      </i>",
"      , 2007, 39(1):16-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/17369082/pubmed\" id=\"17369082\" target=\"_blank\">",
"        17369082",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bomgaars L, Thompson P, Berg S, et al, \"Valacyclovir and Acyclovir Pharmacokinetics in Immunocompromised Children,\"",
"      <i>",
"       Pediatr Blood Cancer",
"      </i>",
"      , 2008, 51(4):504-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/18561175/pubmed\" id=\"18561175\" target=\"_blank\">",
"        18561175",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf%20\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eksborg S, Pal N, Kalin M, et al, \"Pharmacokinetics of Acyclovir in Immunocompromized Children With Leukopenia and Mucositis After Chemotherapy: Can Intravenous Acyclovir Be Substituted by Oral Valacyclovir?\"",
"      <i>",
"       Med Pediatr Oncol",
"      </i>",
"      , 2002, 38(4):240-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/11920787/pubmed\" id=\"11920787\" target=\"_blank\">",
"        11920787",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fish DN, Vidaurri VA, and Deeter RG, \"Stability of Valacyclovir Hydrochloride in Extemporaneously Prepared Oral Liquids,\"",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 1999, 56(19):1957-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/10554914/pubmed\" id=\"10554914\" target=\"_blank\">",
"        10554914",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kimberlin DW, Jacobs RF, Weller S, et al, \"Pharmacokinetics and Safety of Extemporaneously Compounded Valacyclovir Oral Suspension in Pediatric Patients From 1 Month Through 11 years of Age,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2010, 50(2):221-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/20014952/pubmed\" id=\"20014952\" target=\"_blank\">",
"        20014952",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nadal D, Leverger G, Sokal EM, et al, &ldquo;An Investigation of the Steady-State Pharmacokinetics of Oral Valacyclovir in Immunocompromised Children,&rdquo;",
"      <i>",
"       J Infect Dis",
"      </i>",
"      , 2002, 186(Suppl 1):S123-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/12353197/pubmed\" id=\"12353197\" target=\"_blank\">",
"        12353197",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Simon MW, Fish DN, and Deeter RG, &ldquo;Pharmacokinetics and Safety of Valaciclovir in Children With Epstein-Barr Virus Illness,&rdquo;",
"      <i>",
"       Drugs R D",
"      </i>",
"      , 2002, 3(6):365-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?3/35/3638/abstract-text/12516939/pubmed\" id=\"12516939\" target=\"_blank\">",
"        12516939",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13001 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3638=[""].join("\n");
var outline_f3_35_3638=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232799\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232800\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041673\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041707\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232774\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232759\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041713\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041695\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041674\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232826\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232824\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041681\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984816\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041682\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300201\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232768\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2984817\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232770\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F232784\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041715\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041697\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041699\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1041719\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6869964\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6825106\">",
"      Extemporaneous Preparations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13001\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13001|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=related_link\">",
"      Valacyclovir: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?34/45/35540?source=related_link\">",
"      Valacyclovir: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3639="Tachycardia and variable decels with late recovery";
var content_f3_35_3639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F86066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F86066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Tachycardia and variable decels with late recovery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce K Young, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3639=[""].join("\n");
var outline_f3_35_3639=null;
var title_f3_35_3640="Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis";
var content_f3_35_3640=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hepatopulmonary syndrome: Prevalence, causes, clinical manifestations, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Paul A Lange, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3640/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Jess Mandel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3640/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/35/3640/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatopulmonary syndrome is considered present when the following triad exists [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Liver disease",
"     </li>",
"     <li>",
"      Impaired oxygenation",
"     </li>",
"     <li>",
"      Intrapulmonary vascular abnormalities, referred to as intrapulmonary vascular dilatations (IPVDs)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The unique pathological feature of hepatopulmonary syndrome (visualized by autopsy) is gross dilatation of the pulmonary precapillary and capillary vessels, as well as an absolute increase in the number of dilated vessels. A few pleural and pulmonary arteriovenous shunts and portopulmonary anastomoses may also be seen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence, causes, clinical manifestations, and diagnosis of hepatopulmonary syndrome are reviewed here. The natural history, treatment, and outcomes of hepatopulmonary syndrome are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/58/36774?source=see_link\">",
"     \"Hepatopulmonary syndrome: Natural history, treatment, and outcomes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19915116\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates of the prevalence of hepatopulmonary syndrome among patients with chronic liver disease range from 4 to 47 percent, depending upon the diagnostic criteria and methods used [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/2,7-11\">",
"     2,7-11",
"    </a>",
"    ]. These estimates derive primarily from liver transplantation centers. Prospective, multicenter prevalence studies have not been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19914480\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatopulmonary syndrome (HPS) is a complication of liver disease. It is most commonly associated with portal hypertension (with or without cirrhosis), although chronic liver disease of virtually any etiology can be associated with HPS (",
"    <a class=\"graphic graphic_table graphicRef66479 \" href=\"UTD.htm?32/20/33099\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5,12\">",
"     5,12",
"    </a>",
"    ]. In addition, some acute liver diseases have been associated with HPS, such as ischemic hepatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/13\">",
"     13",
"    </a>",
"    ]. No specific type of liver disease, severity of liver disease, or laboratory abnormality predicts HPS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of hepatopulmonary syndrome (HPS) are the consequences of both hepatic and pulmonary dysfunction. More than 80 percent of patients present with symptoms of liver disease; the remainder experience dyspnea as their initial symptom [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hepatic findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with HPS have symptoms and signs of chronic liver disease. These may include weakness, fatigue, anorexia, ascites, a large or small liver, splenomegaly, spider angiomata, palmar erythema, jaundice, asterixis, anasarca, nail changes, digital clubbing, hypertrophic osteoarthropathy, caput medusae, gynecomastia, and testicular atrophy. Some patients will have a history of prior gastrointestinal bleeding due to esophageal or gastric varices, and many will have hemodynamic complications of liver dysfunction:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spider nevi &ndash; Spider nevi are cutaneous lesions that may be a marker of intrapulmonary vascular dilatations directly connecting pulmonary arteries to veins (IPVDs). In one study, patients with cutaneous spider nevi had more systemic and pulmonary vasodilation, more profound gas exchange abnormalities, and less hypoxic pulmonary vasoconstriction than patients without these lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/16\">",
"       16",
"      </a>",
"      ]. The alveolar-arterial (A-a) oxygen gradient was 20 mmHg in patients with spider nevi compared to 8 mmHg in patients without spider nevi. Similarly, the measured shunt fraction",
"      <span class=\"nowrap\">",
"       (Qs/Qt)",
"      </span>",
"      was higher in patients with spider nevi (7.1 versus 2 percent) (",
"      <a class=\"calc calc_professional\" href=\"UTD.htm?1/6/1123?source=see_link\">",
"       calculator 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link&amp;anchor=H5#H5\">",
"       \"Oxygenation and mechanisms of hypoxemia\", section on 'A-a oxygen gradient'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyperdynamic circulation &ndash; A hyperdynamic circulation manifests as three major findings: elevated cardiac output at rest (often exceeding 7",
"      <span class=\"nowrap\">",
"       L/min),",
"      </span>",
"      decreased systemic and pulmonary vascular resistance, and a narrowed arterial-mixed venous oxygen content difference [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=see_link&amp;anchor=H3#H3\">",
"       \"Oxygen delivery and consumption\", section on 'Oxygen content'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Pulmonary findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with HPS eventually develop dyspnea on exertion, at rest, or both, usually after years of liver disease. However, dyspnea is a non-specific finding in patients with liver disease because it may also be the consequence of a hepatic hydrothorax, portopulmonary hypertension, anemia, ascites, fluid retention, and muscle wasting [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5,17\">",
"     5,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30263?source=see_link\">",
"     \"Hepatic hydrothorax\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35064?source=see_link\">",
"     \"Portopulmonary hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Dyspnea may be accompanied by pulmonary findings that are more specific for HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5,18\">",
"     5,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Platypnea &ndash; Platypnea is an increase in dyspnea that is induced by moving into an upright position and relieved by recumbency.",
"     </li>",
"     <li>",
"      Orthodeoxia &ndash; Orthodeoxia refers to a decrease in the arterial oxygen tension (by more than 4 mmHg [0.5 kPa]) or arterial oxyhemoglobin desaturation (by more than 5 percent) when the patient moves from a supine to an upright position, which is improved by returning to the recumbent position. The presence of orthodeoxia in a patient with liver disease is strongly suggestive of HPS, although it can be seen in other situations (eg, post-pneumonectomy, recurrent pulmonary emboli, atrial septal defects, and chronic lung disease) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/19\">",
"       19",
"      </a>",
"      ]. Orthodeoxia affects up to 88 percent of patients with HPS, compared to 5 percent or fewer of patients with cirrhosis alone [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is hypothesized that platypnea and orthodeoxia in HPS are caused by preferential perfusion of IPVDs in the lung bases when the patient is upright [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Hypoxemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoxemia is a common, but non-specific, finding in patients with liver disease. Potential causes include atelectasis due to compression of the lung parenchyma by ascites or pleural fluid, portopulmonary hypertension, and HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/20\">",
"     20",
"    </a>",
"    ]. Severe hypoxemia (PaO",
"    <sub>",
"     2",
"    </sub>",
"    &lt;60 mmHg) in the absence of coexisting cardiopulmonary disease is strongly suggestive of HPS, since atelectasis and portopulmonary hypertension generally cause mild hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. A relationship between the severity of hepatic dysfunction (measured via biochemical indicators or the Child-Pugh classification) and the severity of hypoxemia has not been consistently demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/14,23-25\">",
"     14,23-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HPS-related hypoxemia is due to intrapulmonary vascular dilatations (IPVDs), which range in diameter from 15 to 160 microns [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/26\">",
"     26",
"    </a>",
"    ]. Shunting through the IPVDs leads to ventilation-perfusion mismatch and oxygen diffusion limitation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5,27-30\">",
"     5,27-30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ventilation-perfusion mismatch is a consequence of increased blood flow through the IPVDs in the setting of preserved alveolar ventilation, resulting in the passage of mixed venous blood into the pulmonary veins.",
"     </li>",
"     <li>",
"      The oxygen diffusion limitation is a consequence of diffusion-perfusion impairment (also called alveolar-capillary oxygen disequilibrium) (",
"      <a class=\"graphic graphic_figure graphicRef58856 \" href=\"UTD.htm?8/47/8958\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/31,32\">",
"       31,32",
"      </a>",
"      ]. At room air, the partial pressure (or driving pressure) of oxygen is insufficient for equilibration with blood moving near the center of the alveolar capillary because of the increased diameter of the IPVDs. Supplemental oxygen increases the driving pressure of oxygen and improves oxygenation, which distinguishes IPVDs as physiologic rather than anatomic shunts.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients with mild to moderate HPS-related hypoxemia have modest intrapulmonary shunting, ventilation-perfusion mismatch, and oxygen diffusion limitation. In contrast, severely hypoxemic patients have diffuse dilatation of the pulmonary circulation and loss of hypoxic pulmonary vasoconstriction, which results in a large right-to-left shunt, over-perfusion of poorly ventilated alveoli, and worsening of their ventilation-perfusion mismatch, diffusion limitation, and orthodeoxia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of factors have been postulated to cause IPVDs (",
"    <a class=\"graphic graphic_table graphicRef81686 \" href=\"UTD.htm?23/4/23627\">",
"     table 2",
"    </a>",
"    ). These include failure of the damaged liver to clear circulating pulmonary vasodilators, production of circulating vasodilators by the damaged liver, and inhibition of a circulating vasoconstrictive substance by the damaged liver. Nitric oxide (NO) may also play a pivotal role in the development of IPVDs.",
"   </p>",
"   <p>",
"    An accepted experimental model of HPS is common bile duct ligation in rats. Studies performed using this model support the importance of NO in the pathogenesis of HPS. As an example, one study using this model found that NO-mediated impairment of phenylephrine-induced vasoconstriction, upregulation of endothelial nitric oxide synthase (eNOS) in the intralobar pulmonary arteries, and enhanced eNOS-derived NO production were associated with the development of HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/33\">",
"     33",
"    </a>",
"    ]. The enhanced eNOS-derived NO production may have resulted from pulmonary endothelial endothelin B (ETB) receptor overexpression and increased circulating endothelin-1 (ET-1)-induced vasodilation [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/34\">",
"     34",
"    </a>",
"    ]. The precise trigger for these events remains unclear; however, one possibility is that nitric oxide production is stimulated by absorbed endotoxin (intestinal endotoxemia), which is less efficiently cleared due to portal-systemic shunting and decreased reticuloendothelial cell function in cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/35\">",
"     35",
"    </a>",
"    ]. Further supporting the importance of NO in the development of HPS, another animal study demonstrated that depleting pulmonary intravascular macrophages prevented or reversed HPS; intravascular accumulation of activated CD68+ macrophages in small pulmonary arteries is known to generate angiogenic, proliferative, and vasodilatory growth factors (ie, inducible nitric oxide synthase) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/36\">",
"     36",
"    </a>",
"    ]. While these findings are consistent with the observations in humans with HPS that exhaled NO levels are increased and that administration of nitric oxide inhibitors (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/7/1143?source=see_link\">",
"     methylene blue",
"    </a>",
"    ) can enhance oxygenation, the extent to which these observations can be extrapolated to human disease is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/37-41\">",
"     37-41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3217592\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3217930\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of hepatopulmonary syndrome (HPS) can be made when all of the following abnormalities have been confirmed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Liver disease",
"     </li>",
"     <li>",
"      Impaired oxygenation",
"     </li>",
"     <li>",
"      Intrapulmonary vascular abnormalities, referred to as IPVDs",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Liver disease is already known in most patients who undergo a diagnostic evaluation for suspected HPS. Therefore, this section focuses on the detection of impaired oxygenation and IPVDs. The identification of liver disease is discussed separately in disease-specific topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3218063\">",
"    <span class=\"h2\">",
"     Impaired oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Detection of impaired oxygenation requires that arterial blood gases be drawn with the patient sitting upright at rest. The most sensitive measure of impaired oxygenation is an elevated alveolar-arterial (A-a) oxygen gradient, defined as &ge;15 mmHg when breathing room air (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?30/51/31539?source=see_link\">",
"     calculator 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5\">",
"     5",
"    </a>",
"    ]. An arterial oxygen tension (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) of &lt;80 mmHg also indicates impaired oxygenation. Of note, in patients who are 65 years or older, an A-a gradient &ge;20 mmHg and a PaO",
"    <sub>",
"     2",
"    </sub>",
"    &le;70 mmHg are sometimes used as alternative diagnostic thresholds. The A-a oxygen gradient is the more sensitive of the two measures because it compensates for hyperventilation, which is common in patients with chronic liver disease.",
"   </p>",
"   <p>",
"    The right-to-left shunt fraction is a measure of the degree to which oxygenation is impaired. This can be estimated by measuring the PaO",
"    <sub>",
"     2",
"    </sub>",
"    while the patient wears a nose clip and breathes 100 percent oxygen through a tightly fitting mouthpiece for 20 minutes and then calculating the shunt fraction using the following formula [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/42\">",
"     42",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;",
"    <span class=\"nowrap\">",
"     Qs/Qt",
"    </span>",
"    = ([PAO",
"    <sub>",
"     2",
"    </sub>",
"    - PaO",
"    <sub>",
"     2",
"    </sub>",
"    ] x 0.003) &divide; [([PAO",
"    <sub>",
"     2",
"    </sub>",
"    - PaO",
"    <sub>",
"     2",
"    </sub>",
"    ] x 0.003) + 5]",
"   </p>",
"   <p>",
"    where Qs and Qt refer to shunt and total blood flow, respectively, and PAO",
"    <sub>",
"     2",
"    </sub>",
"    and PaO",
"    <sub>",
"     2",
"    </sub>",
"    refer to the alveolar and arterial partial pressure of oxygen, respectively (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?1/6/1123?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). As a general rule of thumb, the shunt increases 5 percent (above the normal level of 5 percent) for every 100 mmHg drop in PaO",
"    <sub>",
"     2",
"    </sub>",
"    below 600 mmHg. A limitation of this formula is that it assumes that the cardiac output is normal, rather than increased.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3218109\">",
"    <span class=\"h2\">",
"     Intrapulmonary vascular dilatations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic tests that can be used to detect IPVDs include contrast-enhanced echocardiography, technetium-99m-labeled macroaggregated albumin scanning, and pulmonary arteriography. Contrast-enhanced echocardiography is generally preferred because it is more sensitive than technetium-99m-labeled macroaggregated albumin scanning and less invasive than pulmonary arteriography [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3217599\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contrast-enhanced echocardiography is performed by injecting a contrast material intravenously and then performing echocardiography. The contrast material is usually agitated saline (forms a stream of microbubbles 60 to 150 microns in diameter) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/44/32450?source=see_link\">",
"     indocyanine green",
"    </a>",
"    dye. Under normal circumstances, the contrast opacifies only the right heart chambers because it is filtered by the pulmonary capillary bed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/22\">",
"     22",
"    </a>",
"    ]. However, the contrast may opacify the left heart chambers if a right-to-left intracardiac or intrapulmonary shunt is present. With an intracardiac shunt, contrast generally appears in the left heart within three heart beats after injection. In contrast, with an intrapulmonary shunt, contrast generally appears in the left heart three to six heart beats after its appearance in the right heart [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/22\">",
"     22",
"    </a>",
"    ]. In patients with liver disease, detection of an intrapulmonary right-to-left shunt is considered indicative of IPVDs.",
"   </p>",
"   <p>",
"    Contrast-enhanced echocardiography may consist of transthoracic echocardiography or transesophageal echocardiography. Transthoracic echocardiography is generally preferred because it is less invasive, although transesophageal echocardiography detects IPVDs with greater specificity due to direct visualization of microbubbles in the pulmonary veins as they enter the left atrium [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/43\">",
"     43",
"    </a>",
"    ]. Contrast-enhanced echocardiography may be more sensitive when performed in the upright position than in the supine position, probably due to an increase in both the number and size of the shunts [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to emphasize that the detection of IPVDs by contrast-echocardiography in patients with liver disease is insufficient to diagnose HPS; impaired oxygenation is also required. Patients with liver disease can have subclinical pulmonary vasodilatation and, therefore, positive contrast-echocardiography even in the absence of hypoxemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3217606\">",
"    <span class=\"h3\">",
"     Nuclear scanning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Technetium-labeled macroaggregated albumin scanning is an alternative method of identifying possible IPVDs in patients with liver disease. It involves intravenously injecting albumin macroaggregates that should be trapped in the pulmonary capillary bed, since the 20 micron diameter of the macroaggregates exceeds the normal pulmonary capillary diameter of 8 to 15 microns. Scans that identify uptake of the radionuclide by the kidneys",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    brain suggest that the macroaggregates passed through either an intrapulmonary or intracardiac shunt [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/31,45\">",
"     31,45",
"    </a>",
"    ]. The proportion of radionuclide taken up by the kidneys and brain may be used to quantify the shunt.",
"   </p>",
"   <p>",
"    The major limitations of technetium-labeled macroaggregated albumin scanning are its inability to distinguish intrapulmonary from intracardiac shunts and its lower sensitivity than contrast-enhanced echocardiography. Its major advantage is that it accounts for shunting through alveolar vessels that are dilated but still participate in gas exchange, which is not accounted for when the shunt is calculated by breathing 100 percent oxygen [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3217613\">",
"    <span class=\"h3\">",
"     Pulmonary angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary angiography is invasive and, therefore, seldom performed in patients with suspected HPS. It is generally reserved for excluding alternative causes of hypoxemia, such as pulmonary embolism, pulmonary hypertension,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    large direct arteriovenous communications.",
"   </p>",
"   <p>",
"    Three angiographic patterns were described in a study of seven patients with HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/14\">",
"     14",
"    </a>",
"    ]. The type 1 minimal pattern was characterized by normal to finely diffuse, spidery abnormalities. It was associated with severe hypoxemia, orthodeoxia, and a good response to 100 percent inspired oxygen. The type 1 minimal pattern may evolve into a type 1 advanced pattern, which was characterized by a diffuse spongy or blotchy angiographic appearance. It was also associated with severe hypoxemia and orthodeoxia, but may be less responsive to 100 percent oxygen. The type 2 discrete pattern was characterized by localized arteriovenous communications and was associated with a poor response to supplemental oxygen. These findings suggest that pulmonary angiography may provide prognostic information in the future, but additional evidence of this is needed before pulmonary angiography becomes routine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3218214\">",
"    <span class=\"h2\">",
"     Other diagnostic tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other diagnostic tests are frequently performed, since the cause of the patient&rsquo;s symptoms may be uncertain and other diagnoses are being entertained. Among the most common diagnostic tests are chest radiography, high resolution computed tomography (HRCT), and pulmonary function tests.",
"   </p>",
"   <p>",
"    Chest radiographic abnormalities due to HPS are infrequent and subtle. Some patients have increased bibasilar interstitial markings that may be misinterpreted as interstitial lung disease. These markings are probably a manifestation of IPVDs.",
"   </p>",
"   <p>",
"    HRCT of the chest may reveal two characteristic findings of IPVDs, dilated peripheral pulmonary vessels and increased pulmonary artery to bronchus ratios. In an observational study that included ten patients with HPS, 12 patients with normoxemic cirrhosis, and 12 healthy controls, these two findings successfully distinguished the patients with HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/46\">",
"     46",
"    </a>",
"    ]. A novel technique that fuses HRCT and single photon emission computed tomography (SPECT) images that were taken during a deep-inspiratory breath hold may demonstrate perfusion defects that predominantly coincide with subpleural reticulonodular opacities",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dilated vessels in the lung bases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pulmonary function test abnormalities are common, but nonspecific, in patients with HPS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/48\">",
"     48",
"    </a>",
"    ]. Patients with HPS generally have normal expiratory flow rates (unless there is coexisting obstructive or restrictive lung disease) and normal lung volume measurements. However, the diffusing capacity for carbon monoxide (DLCO) is typically mildly to severely impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/48\">",
"     48",
"    </a>",
"    ]. In one series, for example, 15 of 18 patients with HPS had a DLCO less than 80 percent of predicted [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3218117\">",
"    <span class=\"h1\">",
"     DISEASE SEVERITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no universally accepted categorization of the severity of HPS. However, the following has been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3640/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mild &ndash; An alveolar to arterial (A-a) oxygen gradient &ge;15 mmHg and an arterial oxygen tension (PaO",
"      <sub>",
"       2",
"      </sub>",
"      ) &ge;80 mmHg while breathing room air",
"     </li>",
"     <li>",
"      Moderate &ndash; An A-a gradient &ge;15 mmHg and a PaO",
"      <sub>",
"       2",
"      </sub>",
"      in between &ge;60 mmHg and &lt;80 mmHg while breathing room air",
"     </li>",
"     <li>",
"      Severe &ndash; An A-a gradient &ge;15 mmHg and a PaO",
"      <sub>",
"       2",
"      </sub>",
"      in between &ge;50 mmHg and &lt;60 mmHg while breathing room air",
"     </li>",
"     <li>",
"      Very severe &ndash; An A-a gradient &ge;15 mmHg and a PaO",
"      <sub>",
"       2",
"      </sub>",
"      &lt;50 mmHg while breathing room air; alternatively, a PaO",
"      <sub>",
"       2",
"      </sub>",
"      &lt;300 mmHg while breathing 100 percent oxygen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19914389\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Estimates of the prevalence of hepatopulmonary syndrome (HPS) have been highly variable, ranging from 4 to 47 percent. (See",
"      <a class=\"local\" href=\"#H19915116\">",
"       'Prevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      HPS is a complication of liver disease, especially portal hypertension. It is most commonly associated with chronic liver disease, although it has also been reported in the context of acute liver disease (",
"      <a class=\"graphic graphic_table graphicRef66479 \" href=\"UTD.htm?32/20/33099\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H19914480\">",
"       'Causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical features of HPS are due to both hepatic and pulmonary dysfunction. More than 80 percent of patients present with symptoms of liver disease; the remainder experience dyspnea as their initial symptom. Hypoxemia, platypnea, and orthodeoxia are characteristic findings. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of HPS can be made when the following three abnormalities have been identified: liver disease, impaired oxygenation, and intrapulmonary vascular abnormalities (referred to as intrapulmonary vascular dilatations [IPVDs]) (see",
"      <a class=\"local\" href=\"#H3217592\">",
"       'Diagnosis'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The liver disease is already known in most patients who undergo a diagnostic evaluation for suspected HPS.",
"     </li>",
"     <li>",
"      Impaired oxygenation is confirmed when an arterial blood gas demonstrates an alveolar to arterial (A-a) oxygen gradient as &ge;15 mmHg or an arterial oxygen tension (PaO",
"      <sub>",
"       2",
"      </sub>",
"      ) of &lt;80 mmHg while breathing room air.",
"     </li>",
"     <li>",
"      IPVDs may be identified by contrast-enhanced echocardiography, technetium-99m-labeled macroaggregated albumin scanning, and pulmonary arteriography. Contrast-enhanced echocardiography is generally preferred because it is more sensitive than technetium-99m-labeled macroaggregated albumin scanning and less invasive than pulmonary arteriography.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no universally accepted categorization of the severity of HPS. However, a system has been proposed that uses the A-a oxygen gradient and the PaO",
"      <sub>",
"       2",
"      </sub>",
"      to define the severity of HPS. (See",
"      <a class=\"local\" href=\"#H3218117\">",
"       'Disease severity'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/1\">",
"      Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004; 363:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/2\">",
"      Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994; 105:1528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/3\">",
"      Rodr&iacute;guez-Roisin R, Krowka MJ, Herv&eacute; P, et al. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 2004; 24:861.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/4\">",
"      Colle I, Van Steenkiste C, Geerts A, Van Vlierberghe H. Hepatopulmonary syndrome and portopulmonary hypertension: what's new? Acta Gastroenterol Belg 2007; 70:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/5\">",
"      Rodr&iacute;guez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med 2008; 358:2378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/6\">",
"      Fritz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med 2013; 187:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/7\">",
"      Schenk P, Sch&ouml;niger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125:1042.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/8\">",
"      Krowka MJ, Tajik AJ, Dickson ER, et al. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest 1990; 97:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/9\">",
"      Stoller JK, Lange PA, Westveer MK, et al. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med 1995; 163:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/10\">",
"      Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992; 70:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/11\">",
"      Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol 2007; 5:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/12\">",
"      Kaymakoglu S, Kahraman T, Kudat H, et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci 2003; 48:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/13\">",
"      Fuhrmann V, Madl C, Mueller C, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology 2006; 131:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/14\">",
"      Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest 1993; 104:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/15\">",
"      Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis 1993; 13:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/16\">",
"      Rodriguez-Roisin R, Roca J, Agusti AG, et al. Gas exchange and pulmonary vascular reactivity in patients with liver cirrhosis. Am Rev Respir Dis 1987; 135:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/17\">",
"      Kinasewitz GT, Keddissi JI. Hepatic hydrothorax. Curr Opin Pulm Med 2003; 9:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/18\">",
"      Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology 1990; 11:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/19\">",
"      Seward JB, Hayes DL, Smith HC, et al. Platypnea-orthodeoxia: clinical profile, diagnostic workup, management, and report of seven cases. Mayo Clin Proc 1984; 59:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/20\">",
"      Naeije, R, Melot, C, Hallemans, R, et al. Pulmonary hemodynamics in liver cirrhosis. Semin Respir Med 1985; 7:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/21\">",
"      Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med 1989; 10:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/22\">",
"      Lange PA, Stoller JK. The hepatopulmonary syndrome. Ann Intern Med 1995; 122:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/23\">",
"      Vachi&eacute;ry F, Moreau R, Hadengue A, et al. Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations. J Hepatol 1997; 27:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/24\">",
"      Krowka MJ, Wiseman GA, Burnett OL, et al. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest 2000; 118:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/25\">",
"      Whyte MK, Hughes JM, Peters AM, et al. Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome. J Hepatol 1998; 29:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/26\">",
"      Berthelot P, Walker JG, Sherlock S, Reid L. Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med 1966; 274:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/27\">",
"      Andrivet P, Cadranel J, Housset B, et al. Mechanisms of impaired arterial oxygenation in patients with liver cirrhosis and severe respiratory insufficiency. Effects of indomethacin. Chest 1993; 103:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/28\">",
"      Agusti AG, Roca J, Rodriguez-Roisin R, et al. Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. Am Rev Respir Dis 1989; 139:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/29\">",
"      Rodr&iacute;guez-Roisin R, Agust&iacute; AG, Roca J. The hepatopulmonary syndrome: new name, old complexities. Thorax 1992; 47:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/30\">",
"      Hedenstierna G, S&ouml;derman C, Eriksson LS, Wahren J. Ventilation-perfusion inequality in patients with non-alcoholic liver cirrhosis. Eur Respir J 1991; 4:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/31\">",
"      Genovesi MG, Tierney DF, Taplin GV, Eisenberg H. An intravenous radionuclide method to evaluate hypoxemia caused by abnormal alveolar vessels. Limitation of conventional techniques. Am Rev Respir Dis 1976; 114:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/32\">",
"      Davis, HH, Schwartz, DJ, Lefrak, SS, et al. Alveolar-capillary oxygen disequilibrium in hepatic cirrhosis. Chest 1978; 73:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/33\">",
"      Fallon MB, Abrams GA, Luo B, et al. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/34\">",
"      Tang L, Luo B, Patel RP, et al. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 2007; 292:L1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/35\">",
"      Zhang HY, Han DW, Zhao ZF, et al. Multiple pathogenic factor-induced complications of cirrhosis in rats: a new model of hepatopulmonary syndrome with intestinal endotoxemia. World J Gastroenterol 2007; 13:3500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/36\">",
"      Thenappan T, Goel A, Marsboom G, et al. A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med 2011; 183:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/37\">",
"      Martinez-Palli, G, Barbera, JA, Visa, J, et al. Hepatopulmonary syndrome: Prevalence and clinical markers (abstract). Eur Respir J 1996; 9:179S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/38\">",
"      Cremona G, Higenbottam TW, Mayoral V, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8:1883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/39\">",
"      Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis. Hepatology 1997; 26:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/40\">",
"      Nunes H, Lebrec D, Mazmanian M, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001; 164:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/41\">",
"      Schenk P, Madl C, Rezaie-Majd S, et al. Methylene blue improves the hepatopulmonary syndrome. Ann Intern Med 2000; 133:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/42\">",
"      Chiang ST. Anomogram for venous shunt (Qs-Qt) calculation. Thorax 1968; 23:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/43\">",
"      Nemec JJ, Davison MB, Marwick TH, et al. Detection and evaluation of intrapulmonary vascular shunt with \"contrast Doppler\" transesophageal echocardiography. J Am Soc Echocardiogr 1991; 4:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/44\">",
"      Lenci I, Alvior A, Manzia TM, et al. Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation. J Am Soc Echocardiogr 2009; 22:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/45\">",
"      Wolfe JD, Tashkin DP, Holly FE, et al. Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med 1977; 63:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/46\">",
"      K&ouml;ksal D, Ka&ccedil;ar S, K&ouml;ksal AS, et al. Evaluation of intrapulmonary vascular dilatations with high-resolution computed thorax tomography in patients with hepatopulmonary syndrome. J Clin Gastroenterol 2006; 40:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/47\">",
"      Suga K, Kawakami Y, Iwanaga H, et al. Findings of hepatopulmonary syndrome on breath-hold perfusion SPECT-CT fusion images. Ann Nucl Med 2009; 23:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3640/abstract/48\">",
"      Lima BL, Fran&ccedil;a AV, Pazin-Filho A, et al. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc 2004; 79:42.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8248 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-B64CF0B05F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3640=[""].join("\n");
var outline_f3_35_3640=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19914389\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19915116\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19914480\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hepatic findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Pulmonary findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3217592\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3217930\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3218063\">",
"      Impaired oxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3218109\">",
"      Intrapulmonary vascular dilatations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3217599\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3217606\">",
"      - Nuclear scanning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3217613\">",
"      - Pulmonary angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3218214\">",
"      Other diagnostic tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3218117\">",
"      DISEASE SEVERITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19914389\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/8248\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8248|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/47/8958\" title=\"figure 1\">",
"      Oxygen exchange in IPVDs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/8248|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/20/33099\" title=\"table 1\">",
"      Liver diseases and HPS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/4/23627\" title=\"table 2\">",
"      Hormonal mediators of HPS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?1/6/1123?source=related_link\" title=\"calculator 1\">",
"      Calculator: Right to Left Shunt Fraction Qs/Qt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?30/51/31539?source=related_link\" title=\"calculator 2\">",
"      Calculator: A-a gradient (alveolar-arterial gradient; AaG)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30263?source=related_link\">",
"      Hepatic hydrothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/58/36774?source=related_link\">",
"      Hepatopulmonary syndrome: Natural history, treatment, and outcomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31430?source=related_link\">",
"      Oxygen delivery and consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35064?source=related_link\">",
"      Portopulmonary hypertension",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3641="Obesity, weight reduction, and cardiovascular disease";
var content_f3_35_3641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Obesity, weight reduction, and cardiovascular disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Elizabeth Jackson, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Melvyn Rubenfire, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Christopher P Cannon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3641/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/35/3641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is an expanding public health problem worldwide, creating a global health epidemic. According to the World Health Organization, worldwide obesity has doubled since 1980 with 1.5 billion adults considered obese in 2008 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In the United States, 34 percent of US adults aged 20 years and over are overweight, 34 percent are obese, and 6 percent are extremely obese [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In Australia, 54 percent of the population is considered overweight, while 18 percent are obese [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In China nearly one-quarter of the country's total population of 1.3 billion is now overweight [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obesity has long been associated with an increased risk for coronary heart disease (CHD). In a meta-analysis of studies assessing the impact of body weight on CHD, there was a 29 percent increase in CHD for each five-unit increase in body mass index (BMI) (",
"    <a class=\"graphic graphic_table graphicRef63600 \" href=\"UTD.htm?0/22/367\">",
"     table 1A",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74762 \" href=\"UTD.htm?0/9/157\">",
"     table 1B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/6\">",
"     6",
"    </a>",
"    ]. The risk of CHD in obese and overweight persons is compounded by the frequent coexistence of other CHD risk factors such as hypertension, dyslipidemia, and diabetes. How much of the risk is due to obesity alone has been uncertain. Furthermore, the mechanisms by which obesity (particularly abdominal obesity) cause or accelerate coronary atherogenesis are also uncertain.",
"   </p>",
"   <p>",
"    Evidence does exist to suggest that obesity, particularly visceral adipose, among adolescents is associated with acceleration of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. More recently, long-term follow-up from Denmark demonstrated BMI during childhood was positively associated with increased risk of CHD during adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiologic evidence supporting obesity as an independent risk factor, possible mechanisms of action, and the benefit of weight reduction will be reviewed here. The etiology of obesity, other health hazards associated with obesity, and therapy for obesity are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3418?source=see_link\">",
"     \"Etiology and natural history of obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link\">",
"     \"Overview of therapy for obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION OF OBESITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The body mass index (BMI) is the most practical way to evaluate the degree of obesity, although it is not sensitive to body composition. It is calculated from the height and weight as follows:",
"   </p>",
"   <p>",
"    &nbsp;BMI = body weight (in kg) &divide; square of stature (height, in meters)",
"   </p>",
"   <p>",
"    The BMI can be obtained from a nomogram or a table (",
"    <a class=\"graphic graphic_figure graphicRef65305 \" href=\"UTD.htm?12/3/12351\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef63600 graphicRef74762 \" href=\"UTD.htm?28/43/29361\">",
"     table 1A-B",
"    </a>",
"    ). BMI is correlated with body fat and is relatively unaffected by height.",
"   </p>",
"   <p>",
"    Overweight is defined as a BMI between 25 and 29.9",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    and obesity as a BMI of 30",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    or greater. However, when estimating cardiovascular and other risks associated with obesity, both regional fat distribution and comorbid conditions must also be taken into account. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link\">",
"     \"Screening for and clinical evaluation of obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A BMI of 20 to 25",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      is associated with little or no increased risk unless visceral fat is high, or the subject has gained more than 10 kg since age 18.",
"     </li>",
"     <li>",
"      Subjects with a BMI of 26 to 30",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      may be described as having low risk, while those with a BMI of 31 to 35",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      are at moderate risk.",
"     </li>",
"     <li>",
"      Subjects with a BMI of 35 to 40",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      are at high risk, and those with a BMI above 40",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      are at very high risk from their obesity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1082278\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results from the 2007 to 2008 National Health and Nutrition Examination Survey (NHANES) indicate that 34 percent of US adults aged 20 years and over are overweight, 34 percent are obese, and 6 percent are extremely obese [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/3\">",
"     3",
"    </a>",
"    ]. The NHANES 2007 to 2008 data suggest an increase in the prevalence of obesity from a previous level of 23 percent in 1988 to 1994. However, the increases in the prevalence of obesity previously observed do not appear to be continuing over the same rate over past 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Among women, there was no significant change between 1999 to 2000 and 2007 to 2008.",
"     </li>",
"     <li>",
"      Among men, there was a significant linear increase between 1999 to 2000 and 2007 to 2008, but no change between 2003 and 2007 to 2008.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evidence also suggests that the prevalence of overweight among children in the United States has been increasing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/12\">",
"     12",
"    </a>",
"    ]. The prevalence of overweight in 1999 to 2000 increased in several age groups compared to prior data from 1998 to 1994:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ages 12 to 19 years &ndash; 16 percent versus 11 percent previously",
"     </li>",
"     <li>",
"      Ages 6 to 11 years &ndash;15 percent versus 11 percent previously",
"     </li>",
"     <li>",
"      Ages 2 to 5 years &ndash; 10 percent versus 7 percent previously",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Furthermore, the prevalence of overweight among non-Hispanic black and Mexican-American adolescents increased more than 10 percentage points between 1988 to 1994 and 1999 to 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is a relationship between obesity, gender, and age in the United States, with prevalence as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ages 20 to 39 years &ndash; 28 percent of men and 34 percent of women",
"     </li>",
"     <li>",
"      Ages 40 to 59 years &ndash; 34 percent of men and 38 percent of women",
"     </li>",
"     <li>",
"      Ages 60 years and older &ndash; 37 percent of men and 34 percent of women",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OBESITY AND CARDIOVASCULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite uncertainties about the relationship between obesity and CHD, the American Heart Association has identified obesity as an independent risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. This action should heighten clinician awareness about the importance of obesity and stimulate a more vigorous approach to prevention and treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Coronary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 27th Bethesda Conference classified obesity as a category II risk factor, that is, a risk factor for which intervention was likely to lower the incidence of CHD events, based upon the current pathophysiologic understanding and epidemiologic and clinical trial evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/16\">",
"     16",
"    </a>",
"    ]. There is strong, consistent epidemiologic evidence for an association between obesity and CHD, but supporting data from clinical trials are lacking.",
"   </p>",
"   <p>",
"    Many studies have demonstrated a linear, longitudinal relationship between obesity and CHD incidence in univariate analyses, but the relationship has been less certain in multivariate analyses that included serum lipids, diabetes, and hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. As an example, the Munster Heart Study (PROCAM) followed 16,288 men and 7325 women for up to seven years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/19\">",
"     19",
"    </a>",
"    ]. There was a graded positive relationship between BMI and other CHD risk factors including age, total serum cholesterol, low density lipoprotein (LDL) cholesterol, and systolic and diastolic blood pressure in addition to markers of inflammation and thrombosis. The increase of CHD death associated with BMI was completely accounted for and mediated by these risk factors.",
"   </p>",
"   <p>",
"    In contrast, other studies have found that obesity is an independent cardiovascular risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/20-23\">",
"     20-23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Nurses' Health Study evaluated the relationship between BMI and total and cause specific mortality in 115,195 United States women [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/20\">",
"       20",
"      </a>",
"      ]. In multivariate analyses of women who had never smoked, there was a significant trend for increasing risk of death with increasing BMI; compared to women with a BMI &lt;19",
"      <span class=\"nowrap\">",
"       kg/m2,",
"      </span>",
"      the relative risk of death was: 1.2 for a BMI 19 to 24.9",
"      <span class=\"nowrap\">",
"       kg/m2;",
"      </span>",
"      1.3 for a BMI 25 to 26.9",
"      <span class=\"nowrap\">",
"       kg/m2;",
"      </span>",
"      1.6 for a BMI 27 to 28.9",
"      <span class=\"nowrap\">",
"       kg/m2;",
"      </span>",
"      2.1 to 2.2 for a BMI &gt;29",
"      <span class=\"nowrap\">",
"       kg/m2.",
"      </span>",
"      The risk of death was increased at BMI levels well below those considered to indicate obesity, with a striking increase in risk for truly obese women. Weight gain of 10 kg or more after the age of 18 was associated with increased mortality in middle adulthood.",
"      <br/>",
"      <br/>",
"      There was also an association between BMI and cardiovascular mortality. Among women with a BMI of 32 or higher who had never smoked, the relative risk of death from cardiovascular disease was 4.1 compared with women who had a BMI below 19.0.",
"     </li>",
"     <li>",
"      On the basis of data from the National Health and Nutrition Examination Survey, the prevalence of overweight in children between 6 and 11 years of age increased from 4.0 percent in 1971 to 1974 to 17.5 percent in 2001 to 2004 [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/24\">",
"       24",
"      </a>",
"      ]. The prevalence of overweight in adolescents between 12 and 19 years of age increased from 6.1 to 17.0 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/24\">",
"       24",
"      </a>",
"      ]. Furthermore, the Bogalusa Heart Study examined 9167 5- to 17-year olds in seven cross-sectional studies [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/25\">",
"       25",
"      </a>",
"      ]. Although adverse lipid, insulin, and blood pressure levels did not vary substantially with BMI index levels &lt;85",
"      <sup>",
"       th",
"      </sup>",
"      percentile, risk factor prevalence increased greatly at higher levels. About 11 percent of examined school children were considered overweight, while 58 percent of the overweight children were found to have at least one cardiac risk factor.",
"     </li>",
"     <li>",
"      A prospective study followed 1,141,609 subjects over 9.2 years to assess whether BMI is associated with increased mortality risk among Asian men and women. The BMI criteria are essentially derived from studies of European populations, while the validity has yet to be determined in Asian populations. The investigators revealed a U-shaped association between BMI and the risk of death in East Asians, with CVD being the major cause of death for overweight populations, a pattern broadly similar to that seen in previous studies involving mostly North American and European populations. The finding that the same optimal weight range is associated with the lowest risk of death both in Asian and European populations argues strongly against the use of race- or ethnicity-specific BMI cutoffs for overweight and obesity [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Prospective Investigation of the Vasculature in Uppsala Seniors study evaluated 1016 subjects at age 70 to determine if obesity without metabolic disturbances has an increased risk of CVD. Subjects with obesity without metabolic syndrome showed impaired vasoreactivity, a more echolucent carotid artery wall, increased left ventricular mass and function together with impaired",
"      <span class=\"nowrap\">",
"       coagulation/fibrinolysis",
"      </span>",
"      compared with normal-weight subjects without metabolic syndrome. In contrast to previous studies, the data do not support that obesity without metabolic syndrome is a benign condition. This was also the case for overweight individual subjects without metabolic syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Obesity was also found to be an independent risk factor for all-cause mortality in the Framingham Heart Study, which analyzed 30 year follow-up data on male participants [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/21\">",
"       21",
"      </a>",
"      ]. Using Metropolitan Relative Weight criteria, the minimum mortality was seen in the group of men with desirable weight (100 to 109 percent \"normal\"). Multivariate analyses showed a strong positive relationship between baseline weight and death occurring at any interval; the 30 year mortality rate for nonsmoking men who were overweight (weight more than 110 percent desirable weight) was up to 3.9 times higher than men of desirable weight.",
"     </li>",
"     <li>",
"      Another prospective study of over one million adults followed for 14 years found that obesity was strongly associated with an increased risk of all-cause mortality and cardiovascular death among nonsmokers and those without a history of CHD [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/22\">",
"       22",
"      </a>",
"      ]. All-cause mortality was lowest in adults with a BMI between 23.5 and 24.9",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      in men and 22 and 23.4",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      in women; mortality rates progressively increased at higher indices and were highest in the heaviest men and women who had a BMI &ge;40",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      (relative risk 2.7 and 1.9, respectively). A high BMI was most predictive of death from cardiovascular disease, especially in men (relative risk 2.9); significantly increased risks of death from cardiovascular disease were found at all indices greater than 26.5",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      in men and 25",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      in women. The risk associated with BMI was greater for whites than blacks.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, in several large, prospective, long-term studies using multivariate analyses, obesity was an independent risk factor for all-cause mortality and death from CHD in both women and men. However, other studies have observed reduced mortality risk with increasing BMI among patients with a prior history of heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/28\">",
"     28",
"    </a>",
"    ]. Data from over 9000 patients undergoing cardiac catheterization suggest obese patients tend to be younger, and more likely to have single-vessel disease. At one year, patients with normal BMI had higher rates of mortality compared to overweight and obese patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Mechanisms of risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The demonstration that a physical characteristic, biochemical finding, or lifestyle habit is associated with an increased risk of CHD does not by itself establish a casual relationship. Since CHD is a multifactorial disease, a risk factor may be a primary causal agent (eg, LDL cholesterol), or a facilitating causal agent (eg, hypertension, diabetes, and cigarette smoking). Obesity should be viewed in the latter category. Thus, it probably interacts with other risk factors to varying degrees in each individual.",
"   </p>",
"   <p>",
"    There are a number of physiological and metabolic changes associated with obesity that may contribute to an increased risk of cardiovascular disease (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insulin resistance and hyperinsulinemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=see_link\">",
"       \"Insulin resistance: Definition and clinical spectrum\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Type 2 diabetes mellitus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7578?source=see_link\">",
"       \"Glycemic control and vascular complications in type 2 diabetes mellitus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Lipid abnormalities, including low HDL level, high triglyceride level, increased apolipoprotein B level (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link\">",
"       \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Systolic and diastolic hypertension (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37685?source=see_link\">",
"       \"Cardiovascular risks of hypertension\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Left ventricular hypertrophy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link\">",
"       \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Sympathetic nervous system dysfunction",
"     </li>",
"     <li>",
"      Endothelial dysfunction (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=see_link\">",
"       \"Endothelial dysfunction\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Obstructive sleep apnea (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18169?source=see_link\">",
"       \"Cardiovascular effects of obstructive sleep apnea\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h4\">",
"     Metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visceral or abdominal obesity is associated with insulin resistance and an array of metabolic and hemodynamic disorders, including hyperinsulinemia, atherogenic blood lipid changes, hypertension, and type 2 diabetes. This constellation of findings has been called the metabolic syndrome (or insulin resistance syndrome or syndrome X). The prevalence of the metabolic syndrome is significantly higher in patients with than without a history of cardiovascular disease. Patients who have metabolic syndrome have a threefold increased risk for developing CHD or stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=see_link\">",
"     \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h4\">",
"     Type 2 diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type 2 diabetes mellitus is strongly associated with obesity in all ethnic groups. More than 80 percent of cases of type 2 diabetes can be attributed to obesity, which may also account for many diabetes-related deaths. CHD is more common in diabetics than in the general population, affecting as many as 55 percent of patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link&amp;anchor=H9#H9\">",
"     \"Health hazards associated with obesity in adults\", section on 'Diabetes mellitus'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27226?source=see_link\">",
"     \"Prevalence of and risk factors for coronary heart disease in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Hyperlipidemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is associated with several deleterious changes in lipid metabolism, including high serum concentrations of total cholesterol, low-density lipoprotein (LDL) cholesterol, very-low-density lipoprotein (VLDL)-cholesterol, and triglycerides, and a reduction in serum HDL cholesterol of about 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. The last effect may be most important since a low serum HDL cholesterol concentration carries a greater relative risk of CHD than hypertriglyceridemia. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=see_link\">",
"     \"Lipoprotein classification; metabolism; and role in atherosclerosis\"",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    Central fat distribution also plays an important role in the serum lipid abnormalities. Waist circumference alone accounts for as much or more of the variance in serum triglyceride and HDL cholesterol concentrations as either the WHR [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood pressure is often increased in obese subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/34\">",
"     34",
"    </a>",
"    ]. In the Swedish Obesity Study, for example, hypertension was present at baseline in approximately one-half of subjects. In a report from the Nurses' Health Study, the BMI at age 18 years and at midlife was positively associated with the occurrence of hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/35\">",
"     35",
"    </a>",
"    ]. Weight gain was also associated with an increased risk; the relative risk of hypertension in those women who gained 5.0 to 9.9 kg and &ge;25.0 kg was 1.7 and 5.2, respectively. (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37685?source=see_link\">",
"     \"Cardiovascular risks of hypertension\"",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h4\">",
"     Left ventricular hypertrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity is associated with volume overload resulting in a high end-diastolic volume and increased filling pressure. This, coupled with hypertension, can lead to left ventricular hypertrophy (LVH) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/36\">",
"     36",
"    </a>",
"    ]. LVH is important clinically because it is associated with an enhanced incidence of heart failure, ventricular arrhythmias, death following MI, and sudden cardiac death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link\">",
"     \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h4\">",
"     Sympathetic nervous system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Obesity may be associated with abnormalities in sympathetic nervous system control. This can predispose obese individuals to prolonged QT intervals and arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=see_link\">",
"     \"Pathogenesis of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h4\">",
"     Sleep apnea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleep apnea is associated with obesity [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/38\">",
"     38",
"    </a>",
"    ]. The syndrome is related to excess mortality, hypertension, left and right ventricular dysfunction, and arrhythmias. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18169?source=see_link\">",
"     \"Cardiovascular effects of obstructive sleep apnea\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the association with coronary heart disease, there is an important association between obesity and heart failure. In an analysis from the Framingham Heart Study in which almost 6000 individuals without a history of heart failure (mean age 55 years) were followed for a mean of 14 years [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/39\">",
"     39",
"    </a>",
"    ]; heart failure developed in 496 (8.4 percent). The risk of heart failure was increased approximately twofold higher in obese (body mass index [BMI] &ge;30",
"    <span class=\"nowrap\">",
"     kg/m2)",
"    </span>",
"    compared with nonobese subjects. After adjusting for established risk factors (eg, hypertension, coronary disease, diabetes, left ventricular hypertrophy), the risk of heart failure increased 5 percent in men and 7 percent in women for each increment of 1",
"    <span class=\"nowrap\">",
"     kg/m2",
"    </span>",
"    in BMI. Approximately 11 percent of cases of heart failure in men and 14 percent in women could be attributed to obesity alone. The risk was also increased in overweight (BMI 25 to 29.9",
"    <span class=\"nowrap\">",
"     kg/m2)",
"    </span>",
"    women but not men. However, among patients with a history of heart failure, increasing BMI appears protective. Several studies have observed lower rates of rehospitalization and death among heart failure overweight and obese heart failure patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15497?source=see_link\">",
"     \"Epidemiology and causes of heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     ECG in morbid obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbid obesity can produce changes in cardiac morphology that can alter the surface ECG. This was revealed in a study that compared the ECG of 100 obese subjects and 100 controls; none of the subjects had clinical, ECG, radiographic, or echocardiographic evidence of coronary heart disease, systemic hypertension, valvular heart disease, heart failure, cardiomyopathy, or pericardial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/42\">",
"     42",
"    </a>",
"    ]. Compared to controls, obese patients had the following alterations on the ECG:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      P, QRS, and T wave axes were more leftward",
"     </li>",
"     <li>",
"      Low QRS voltage, multiple ECG criteria for left ventricular hypertrophy and left atrial abnormality, and T wave flattening in the inferior and lateral leads were more common",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Abdominal obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;At any given level of BMI, the risk of the development of cardiovascular disease in both men and women is increased by more abdominal fat (increased waist to hip ratio, WHR) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link&amp;anchor=H8#H8\">",
"     \"Screening for and clinical evaluation of obesity in adults\", section on 'Waist circumference'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relationship between abdominal obesity and cardiovascular mortality was evaluated in a cohort of 44,636 women in the Nurses' Health Study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/44\">",
"     44",
"    </a>",
"    ]. The relative risk increased significantly from the lowest to the highest waist circumference quintiles (1.00, 1.04, 1.04, 1.28 and 1.99 respectively) after adjustment for body mass index and other confounders during 16 years of follow-up. This relationship persisted even among normal weight women (body mass index 18.5 to",
"    <span class=\"nowrap\">",
"     &lt;25kg/m2).",
"    </span>",
"   </p>",
"   <p>",
"    Additionally, BMI and waist-to-hip ratio were compared in a study of 27,098 patients in 52 countries to assess the degree of myocardial infarction. BMI showed a modest and graded association with myocardial infarction (OR 1.44, 95% CI: 1.32-1.57), which was substantially reduced after adjustment for waist-to-hip ratio (1.12, 1.03-1.22) and non-significant after adjustment for other risk factors (0.98, 0.88-1.09). For waist-to-hip ratio, the odds ratios for every successive quintile were significantly greater than that of the previous one (4",
"    <sup>",
"     th",
"    </sup>",
"    quintile: 1.90, 1.74-2.07 and 5",
"    <sup>",
"     th",
"    </sup>",
"    quintile 2.52,",
"    <span class=\"nowrap\">",
"     2/31-2.74)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     BENEFITS OF WEIGHT LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight loss can improve or prevent many of the obesity-related risk factors for cardiovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/46\">",
"     46",
"    </a>",
"    ]. Benefits include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Decreased blood pressure in hypertensive patients [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/47,48\">",
"       47,48",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Decreased incidence of diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Improved lipid profile",
"     </li>",
"     <li>",
"      Decreased insulin resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/51\">",
"       51",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Reduced C-reactive protein concentration [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/52\">",
"       52",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Improved endothelial function [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/53\">",
"       53",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of therapy for obesity in adults\", section on 'Benefits of weight loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Achieving and maintaining weight loss is made difficult by the reduction in energy expenditure that is induced by weight loss. In addition, recidivism (regaining of lost weight) is a common problem; of those subjects who lose weight during any treatment program, most do not maintain the weight loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link&amp;anchor=H11#H11\">",
"     \"Overview of therapy for obesity in adults\", section on 'Importance of weight loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the limited data regarding the long-term benefits of weight loss and the difficulties with achieving and maintaining weight loss, health care providers should urge patients with known cardiovascular disease or cardiovascular risk factors (eg, hypertension, dyslipidemia, type 2 diabetes mellitus) to lose weight. For persons free of disease, prevention of obesity beginning in early life is a sound recommendation. For individuals older than 75, excess body weight does not appear to be an important risk factor.",
"   </p>",
"   <p>",
"    We agree with the 2007",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    focused update of the 2002 guidelines for the management of patients with chronic stable angina, which made the following recommendations for weight management [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/54\">",
"     54",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Regular assessment of BMI and waist circumference.",
"     </li>",
"     <li>",
"      Counseling on weight management at each patient visit, with a goal of a BMI between 18.5 and 24.9",
"      <span class=\"nowrap\">",
"       kg/m2.",
"      </span>",
"     </li>",
"     <li>",
"      The initial goal of weight loss should be approximately 10 percent from baseline.",
"     </li>",
"     <li>",
"      Recommend lifestyle changes and consider treatment strategies for metabolic syndrome in women if the waist circumference is &ge;35 inches (89 cm) or &ge;40 inches (102 cm) in men. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=see_link&amp;anchor=H15#H15\">",
"       \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\", section on 'Therapy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Drug therapy may be a helpful component of treatment for overweight subjects. However, among patients with CVD, certain drugs may be contraindicated. Anti-obesity drugs have been used as an adjunct to diet and exercise for obese subjects with a BMI greater than 30",
"    <span class=\"nowrap\">",
"     kg/m2.",
"    </span>",
"    The role of drug therapy has been questioned, however, because of concerns about efficacy, the potential for abuse, and side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=see_link\">",
"     \"Drug therapy of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgery (gastric bypass or banding) is another option for patients at high risk of complications from obesity. Like dietary weight loss, gastrointestinal obesity surgery can reduce cardiovascular risk factors, including blood pressure, diabetes incidence, and lipid profile [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/55\">",
"     55",
"    </a>",
"    ]. However, this does not appear to occur with liposuction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3641/abstract/56\">",
"     56",
"    </a>",
"    ], suggesting that the negative energy balance associated with decreased nutritional intake may be necessary for achieving the metabolic benefits of weight loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=see_link\">",
"     \"Surgical management of severe obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1082501\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Obesity is an expanding public health problem, with a doubling of the prevalence of worldwide obesity since 1980 resulting 1.5 billion adults who were considered obese in 2008. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The body mass index (BMI) is the most practical way to evaluate the degree of obesity, although it is not sensitive to body composition. BMI is equal to body weight (in kg) divided by square of stature (height, in meters), but can be more easily obtained from a nomogram or table (",
"      <a class=\"graphic graphic_figure graphicRef65305 \" href=\"UTD.htm?12/3/12351\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63600 graphicRef74762 \" href=\"UTD.htm?28/43/29361\">",
"       table 1A-B",
"      </a>",
"      ). Overweight is defined as a BMI between 26 and 30",
"      <span class=\"nowrap\">",
"       kg/m2",
"      </span>",
"      and obesity as a BMI greater than 30",
"      <span class=\"nowrap\">",
"       kg/m2.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Definition of obesity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Obesity is an independent risk factor for the development of coronary heart disease (CHD), although the exact extent of the relationship has been variable in different populations of patients. Obesity is also associated with a greater risk of overall and cardiovascular mortality as well as the development of heart failure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Coronary disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Heart failure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      At any given level of BMI, the risk of the development of cardiovascular disease in both men and women is increased by greater amounts of abdominal fat, resulting in an increased waist to hip ratio. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Abdominal obesity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Health care providers should urge patients with known cardiovascular disease or cardiovascular risk factors (eg, hypertension, dyslipidemia, type 2 diabetes mellitus) to lose weight. Dietary and lifestyle modifications should be the initial approach in the majority of patients, with pharmacologic and surgical therapy considered in selected patients. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Benefits of weight loss'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     file://www.who.int/mediacentre (Accessed on August 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/2\">",
"      Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301:2129.",
"     </a>",
"    </li>",
"    <li>",
"     Ogden CL, Carroll MD. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960-1962 Through 2007-2008. National Center for Health Statistics; 2010.",
"    </li>",
"    <li>",
"     AIHW 2006. Australia's health 2006. Australia's health no. 10. Cat. no. AUS 73. Canberra: AIHW.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/5\">",
"      Wu YF, Ma GS, Hu YH, et al. [The current prevalence status of body overweight and obesity in China: data from the China National Nutrition and Health Survey]. Zhonghua Yu Fang Yi Xue Za Zhi 2005; 39:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/6\">",
"      Bogers RP, Bemelmans WJ, Hoogenveen RT, et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167:1720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/7\">",
"      McGill HC Jr, McMahan CA, Malcom GT, et al. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995; 15:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/8\">",
"      Lee CD, Jacobs DR Jr, Schreiner PJ, et al. Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 2007; 86:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/9\">",
"      Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008; 371:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/10\">",
"      Baker JL, Olsen LW, S&oslash;rensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007; 357:2329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/11\">",
"      Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/12\">",
"      Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288:1728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/13\">",
"      Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96:3248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/14\">",
"      Krauss RM, Winston M, Fletcher RN, Grundy SM. Obesity: impact of cardiovascular disease. Circulation 1998; 98:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/15\">",
"      Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/16\">",
"      27th Bethesda Conference. Matching the Intensity of Risk Factor Management with the Hazard for Coronary Disease Events. September 14-15, 1995. J Am Coll Cardiol 1996; 27:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/17\">",
"      Jousilahti P, Tuomilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 1996; 93:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/18\">",
"      Emerging Risk Factors Collaboration, Wormser D, Kaptoge S, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377:1085.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/19\">",
"      Schulte H, Cullen P, Assmann G. Obesity, mortality and cardiovascular disease in the M&uuml;nster Heart Study (PROCAM). Atherosclerosis 1999; 144:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/20\">",
"      Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995; 333:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/21\">",
"      Garrison RJ, Castelli WP. Weight and thirty-year mortality of men in the Framingham Study. Ann Intern Med 1985; 103:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/22\">",
"      Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/23\">",
"      Empana JP, Ducimetiere P, Charles MA, Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men: the Paris Prospective Study I. Circulation 2004; 110:2781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/24\">",
"      Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/25\">",
"      Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999; 103:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/26\">",
"      Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011; 364:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/27\">",
"      Lind L, Siegbahn A, Ingelsson E, et al. A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 2011; 31:e27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/28\">",
"      Uretsky S, Messerli FH, Bangalore S, et al. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/29\">",
"      Gruberg L, Weissman NJ, Waksman R, et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/30\">",
"      Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/31\">",
"      Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/32\">",
"      Grundy SM, Barnett JP. Metabolic and health complications of obesity. Dis Mon 1990; 36:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/33\">",
"      Pouliot MC, Despr&eacute;s JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/34\">",
"      Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci 1993; 306:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/35\">",
"      Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med 1998; 128:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/36\">",
"      Koch R, Sharma AM. Obesity and cardiovascular hemodynamic function. Curr Hypertens Rep 1999; 1:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/37\">",
"      Corry DB, Tuck ML. Obesity, hypertension, and sympathetic nervous system activity. Curr Hypertens Rep 1999; 1:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/38\">",
"      Narkiewicz K, Somers VK. Obstructive sleep apnea as a cause of neurogenic hypertension. Curr Hypertens Rep 1999; 1:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/39\">",
"      Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/40\">",
"      Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/41\">",
"      Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001; 38:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/42\">",
"      Alpert MA, Terry BE, Cohen MV, et al. The electrocardiogram in morbid obesity. Am J Cardiol 2000; 85:908.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/43\">",
"      Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/44\">",
"      Zhang C, Rexrode KM, van Dam RM, et al. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/45\">",
"      Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366:1640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/46\">",
"      Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2004; 110:2952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/47\">",
"      Stevens VJ, Corrigan SA, Obarzanek E, et al. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med 1993; 153:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/48\">",
"      Horvath K, Jeitler K, Siering U, et al. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Arch Intern Med 2008; 168:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/49\">",
"      Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/50\">",
"      Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/51\">",
"      Weinstock RS, Dai H, Wadden TA. Diet and exercise in the treatment of obesity: effects of 3 interventions on insulin resistance. Arch Intern Med 1998; 158:2477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/52\">",
"      Tchernof A, Nolan A, Sites CK, et al. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002; 105:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/53\">",
"      Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105:804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/54\">",
"      Fraker TD Jr, Fihn SD, 2002 Chronic Stable Angina Writing Committee, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina. J Am Coll Cardiol 2007; 50:2264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/55\">",
"      Sj&ouml;str&ouml;m CD, Lissner L, Wedel H, Sj&ouml;str&ouml;m L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3641/abstract/56\">",
"      Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350:2549.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1529 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-8913731101-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3641=[""].join("\n");
var outline_f3_35_3641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1082501\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION OF OBESITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1082278\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OBESITY AND CARDIOVASCULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Coronary disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Mechanisms of risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Hyperlipidemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Left ventricular hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sympathetic nervous system",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      ECG in morbid obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Abdominal obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      BENEFITS OF WEIGHT LOSS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1082501\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1529\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1529|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/3/12351\" title=\"figure 1\">",
"      Nomogram for BMI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1529|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/22/367\" title=\"table 1A\">",
"      Determining BMI A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/9/157\" title=\"table 1B\">",
"      Determining BMI B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/47/18169?source=related_link\">",
"      Cardiovascular effects of obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/51/37685?source=related_link\">",
"      Cardiovascular risks of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=related_link\">",
"      Drug therapy of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/39/23162?source=related_link\">",
"      Endothelial dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15497?source=related_link\">",
"      Epidemiology and causes of heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3418?source=related_link\">",
"      Etiology and natural history of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/25/7578?source=related_link\">",
"      Glycemic control and vascular complications in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28567?source=related_link\">",
"      Insulin resistance: Definition and clinical spectrum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/45/18138?source=related_link\">",
"      Lipoprotein classification; metabolism; and role in atherosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=related_link\">",
"      Overview of therapy for obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13929?source=related_link\">",
"      Pathogenesis of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27226?source=related_link\">",
"      Prevalence of and risk factors for coronary heart disease in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=related_link\">",
"      Screening for and clinical evaluation of obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/31/33274?source=related_link\">",
"      Surgical management of severe obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3642="Transbronchial needle aspiration";
var content_f3_35_3642=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transbronchial needle aspiration",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Omar A Minai, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Atul C Mehta, MBBS, FCCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/35/3642/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/35/3642/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transbronchial needle aspiration (TBNA) of mediastinal lymph nodes was initially described in 1949 and its application via flexible bronchoscopy was later described in 1981 [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Since then, its utility in the diagnosis of endobronchial, peripheral, and mediastinal lesions has been reported in research publications and confirmed with widespread clinical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/7-14\">",
"     7-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TBNA provides an opportunity to diagnose and stage pulmonary and mediastinal lesions (particularly lung cancer) in a minimally invasive fashion, even in the absence of endobronchial disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Despite such advantages, TBNA is underutilized [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/18,19\">",
"     18,19",
"    </a>",
"    ], a trend that may change since trainees are increasingly gaining experience with the technique [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of TBNA in the diagnosis of central and peripheral lesions is reviewed here. In addition, anatomic and technical considerations are discussed. The staging of non-small cell lung cancer is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for TBNA are summarized in the table (",
"    <a class=\"graphic graphic_table graphicRef57818 \" href=\"UTD.htm?20/21/20827\">",
"     table 1",
"    </a>",
"    ). The most common application of TBNA is the diagnosis and staging of lung cancer. However, TBNA can also be used to sample endobronchial, submucosal, peribronchial (when extrinsic compression exists), or peripheral lesions. TBNA may be the only diagnostic modality that can be performed in patients in whom mediastinoscopy is contraindicated due to a bleeding diathesis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/15,16,22\">",
"     15,16,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TECHNICAL CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are numerous factors that influence the diagnostic yield of TBNA. They include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Likelihood of malignancy, as determined from the history and physical examination",
"     </li>",
"     <li>",
"      Location of the lesion or lymph node, size of the lesion or lymph node, and appearance of the lesion (eg, spiculation), as determined by computed tomography (CT)",
"     </li>",
"     <li>",
"      Visibility and carinal involvement of the tumor, as determined by bronchoscopy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, technical issues can influence diagnostic yield, including operator experience, the type of needle, the number of attempts, the number of aspirates, and the presence of a cytologist.",
"   </p>",
"   <p>",
"    Essentials of the TBNA procedure (the \"six T's\"), computed tomography, type of needle, technique, tissue preparation, tissue interpretation, and trained assistant, should be considered every time a TBNA is performed (",
"    <a class=\"graphic graphic_table graphicRef51774 \" href=\"UTD.htm?2/28/2507\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT is typically performed prior to bronchoscopy and TBNA in order to evaluate the relationship of the tracheobronchial tree to the surrounding structures, including lymph nodes and blood vessels. This maximizes diagnostic yield and safety [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Virtual bronchoscopy, a CT-based technique that allows the presentation of computer-generated intraluminal images, may be helpful in planning complex procedures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link&amp;anchor=H19909537#H19909537\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\", section on 'Virtual bronchoscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Location of the lymph nodes &ndash; Aspiration of only five stations (out of 11 that are accessible to TBNA) is useful for staging of lung cancer [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/23,25\">",
"       23,25",
"      </a>",
"      ]. Aspiration of the remainder is undertaken to increase the chances of making a tissue diagnosis, but is not helpful for staging. The most recent International Association for the Study of Lung Cancer (IASCL) lymph node map is shown in the figure (",
"      <a class=\"graphic graphic_figure graphicRef73945 \" href=\"UTD.htm?19/28/19914\">",
"       figure 1",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      TBNA of lymph nodes in the subcarinal and right paratracheal regions detects metastasis with a higher sensitivity than TBNA of left paratracheal lymph nodes [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/26\">",
"       26",
"      </a>",
"      ]. In addition, TBNA of mediastinal lymph nodes performed for diagnosis and staging of a tumor in the right lung is more sensitive than that performed for a tumor in the left lung [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/27,28\">",
"       27,28",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The location of the lymph nodes in relation to the tracheobronchial tree is best visualized by imagining the interior of the airway as a clock face, using the carina as the central reference point. The best approach for each station with the bronchoscopist standing behind the patient lying in a supine position is outlined in the table (",
"      <a class=\"graphic graphic_table graphicRef59333 \" href=\"UTD.htm?0/40/652\">",
"       table 3",
"      </a>",
"      ). To obtain an adequate specimen, the needle must reach the core of the lymph node while avoiding nearby vascular structures (",
"      <a class=\"graphic graphic_figure graphicRef54056 graphicRef73983 graphicRef65244 \" href=\"UTD.htm?28/50/29480\">",
"       figure 2A-C",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Anteriorly and to the right of the distal third of the trachea are found the superior vena cava and the azygos vein. Directly anterior to the trachea, above the level of the primary carina, lie the innominate artery and the aortic arch. They cross the origin of the left mainstem bronchus and then lie anterior and to the left of the distal third of the trachea, making an easily recognizable pulsatile imprint [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/24\">",
"       24",
"      </a>",
"      ]. The main pulmonary artery divides into the right and left branches within the concavity of the aortic arch. The left pulmonary artery runs anterosuperiorly, in close approximation (within 3 to 5 mm) to the left mainstem bronchus, while the right pulmonary artery lies anterior to the right mainstem bronchus and the origin of the upper lobe bronchus. The esophagus lies in close approximation (within 2 to 3 mm) to the posterior wall of the trachea and the left mainstem bronchus [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/29\">",
"       29",
"      </a>",
"      ]. When TBNA is performed, these areas should be avoided unless a clearly visualized pathologic process is documented by radiographic evaluation.",
"     </li>",
"     <li>",
"      Size of the lesion and lymph nodes &ndash; Mediastinal lymph nodes that appear enlarged on a CT scan (&gt;1 cm) have better diagnostic yield from TBNA than those that do not appear enlarged (&lt;1 cm) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/28,30,31\">",
"       28,30,31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Type of needle",
"    </span>",
"    &nbsp;&mdash;&nbsp;A wide variety of biopsy needles are available, but we recommend familiarizing oneself and the bronchoscopy suite staff with no more than one or two needles for each indication.",
"   </p>",
"   <p>",
"    All needle systems for transbronchial aspiration consist of [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A retractable sharp beveled flexible needle",
"     </li>",
"     <li>",
"      A flexible catheter",
"     </li>",
"     <li>",
"      A proximal control device to manipulate the needle, the stylet, or both, and a side port through which suction can be applied",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Only retractable needles should be used, because non-retractable needles may damage the working channel of the bronchoscope. The 20 to 22 G needles are usually used to obtain cytology specimens while the larger 19 G needles are needed to obtain a core of tissue for histology [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. For lesions located outside the airway wall, the needle should be at least 10 mm in length. A needle 15 mm in length and 21 G in diameter is necessary for the aspiration of a mediastinal abscess or cyst.",
"   </p>",
"   <p>",
"    The catheter should be flexible enough to maneuver into peripheral locations, yet stiff enough to exert force to penetrate the thick proximal bronchial wall to sample central lesions. Additional rigidity is provided by a metal stylet.",
"   </p>",
"   <p>",
"    Histology specimens may be obtained from central lesions using a trocar and cannula design involving 21 G and 19 G beveled, retractable needles [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/32\">",
"     32",
"    </a>",
"    ]. The 21 G, 5 mm long needle (trocar) facilitates insertion of the 19 G, 15 mm long needle (cannula), prevents inadvertent puncture of the major vessels by the latter, and prevents plugging by the tracheobronchial wall cartilage.",
"   </p>",
"   <p>",
"    One study of the sensitivity of 22 G and 19 G needles for the staging of lung cancer in 55 patients with proven malignant mediastinal adenopathy found that the sensitivity of the 19 G needle was significantly higher, and that combining both 22 G and 19 G aspirations in the same patient provided the best diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/35\">",
"     35",
"    </a>",
"    ]. Overall, the 22 G needle correctly identified only 29 patients (53 percent), while the 19 G needle correctly identified 47 patients (85 percent).",
"   </p>",
"   <p>",
"    The size of needle used to perform TBNA in specific patient populations is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef73427 \" href=\"UTD.htm?13/10/13483\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;A coagulation profile is not needed in the absence of a history of a bleeding diathesis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/36\">",
"     36",
"    </a>",
"    ]. Transbronchial needle aspiration can be safely and successfully performed for unexpected endobronchial lesions encountered during routine fiberoptic bronchoscopy. Conventional fluoroscopy is required for sampling peripheral lesions, and CT fluoroscopy can facilitate biopsy of smaller or more inaccessible mediastinal or parenchymal lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/37-39\">",
"     37-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During insertion of the catheter, the flexible bronchoscope should be kept as straight as possible, with its distal tip in the neutral position in order to prevent damage to the working channel by the needle. The beveled end of the needle should be kept within the metal hub during its passage through the working channel [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/40,41\">",
"     40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The needle should be advanced and locked into place once the metal hub is visible beyond the tip of the fiberoptic bronchoscope. The catheter should be retracted, and the tip of the needle kept distal to that of the fiberoptic bronchoscope. The bronchoscope is then advanced to the target area, and the tip of the needle is anchored in the intercartilaginous space so as to penetrate the airway wall in as perpendicular manner as possible, with a needle to wall angle &gt;45 degrees (",
"    <a class=\"graphic graphic_figure graphicRef70074 \" href=\"UTD.htm?21/58/22432\">",
"     figure 3",
"    </a>",
"    ). Protruding the catheter more than a few millimeters beyond the tip of the bronchoscope may kink it, leading to difficulty in attaining proper needle position, penetration, and aspiration. Using the working channel to splint the distal end of the catheter further facilitates sampling.",
"   </p>",
"   <p>",
"    The techniques that may be used to insert the needle through the airway wall are shown in the figure and described in the table (",
"    <a class=\"graphic graphic_figure graphicRef78961 graphicRef69955 graphicRef73571 \" href=\"UTD.htm?8/6/8293\">",
"     figure 4A-C",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74513 \" href=\"UTD.htm?36/21/37211\">",
"     table 5",
"    </a>",
"    ). These techniques may be used alone or in combination for successful penetration of the needle through the tracheobronchial wall. The needle should be inserted to its fullest extent with the metal hub flush against the tracheobronchial wall (",
"    <a class=\"graphic graphic_figure graphicRef78323 \" href=\"UTD.htm?31/40/32399\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    With the needle inserted, suction is applied at the proximal side port using a 60 mL syringe. Aspiration of blood indicates inadvertent penetration of a major intrathoracic vessel; if this occurs, suction is released, the needle is retracted, and a new site is selected for aspiration. If no blood is aspirated, the catheter is agitated to and fro to obtain cytology specimens and is moved in and out by 3 to 4 millimeters to obtain histology specimens, with continuous suction, in an attempt to shear off cells from the mass or lymph node. The needle is withdrawn from the target site after releasing suction. The tip of the bronchoscope is straightened and the needle assembly removed from the bronchoscope in a single, smooth motion [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Use of the 19 G needle assembly and a variation of the technique used to obtain cytology specimens allows obtaining histology samples via TBNA. The assembly is passed until only the distal metal hub is seen beyond the tip of the bronchoscope, while taking the same precautions as with the cytology needle. Once the metal hub is visible, the 19 G needle is advanced and locked into place beyond the metal hub (",
"    <a class=\"graphic graphic_figure graphicRef71049 \" href=\"UTD.htm?27/5/27729\">",
"     figure 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The automatically advanced 21 G needle is used to puncture the airway wall and is anchored at the target site by any of the techniques previously described (",
"    <a class=\"graphic graphic_figure graphicRef71049 \" href=\"UTD.htm?27/5/27729\">",
"     figure 6",
"    </a>",
"    ). Using a 60 mL syringe containing 3 mL of normal saline, suction is applied at the proximal port to ascertain the safety of the location.",
"   </p>",
"   <p>",
"    This is followed by insertion of the 19 G needle to its fullest extent (",
"    <a class=\"graphic graphic_figure graphicRef71049 \" href=\"UTD.htm?27/5/27729\">",
"     figure 6",
"    </a>",
"    ) and withdrawal of the 21 G needle. Under continuous suction, the 19 G needle is moved to and fro 4 to 5 times to obtain a core of tissue. The needle is flushed into the preservative to obtain the specimen, although on occasion the 21 G needle may be required to push the core out of the 19 G needle. Successful sampling is indicated by visualizing a definite core of tissue at the bottom of the preservative container.",
"   </p>",
"   <p>",
"    Submucosal lesions may be sampled by incomplete penetration of the airway wall at an acute angle, while applying suction. Sampling of endobronchial lesions may be performed by fully embedding the needle in the lesion, oriented parallel to the airway wall, and agitating to and fro repeatedly, with continuous suction. Sampling of peripheral lesions is best performed under fluoroscopic guidance, placing the metal hub of the needle against the lesion before pushing the needle into the lesion. For more difficult to reach lesions, the needle may be advanced in a major airway and then guided into the lesion under fluoroscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The number of aspirations performed at each target site impacts diagnostic yield. One study found that the diagnostic yield increased incrementally until the seventh aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/42\">",
"     42",
"    </a>",
"    ]. A subsequent study reported similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/43\">",
"     43",
"    </a>",
"    ]. However, the latter study also indicated that three passes were sufficient only when alternate sampling sites were available and that four or five passes should be performed at nodal stations critical for staging.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Tissue preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper handling of the obtained specimen is a critical and underappreciated aspect of the procedure. The specimen for cytology is prepared by using air from a 60 mL empty syringe to spray the specimen onto the slide, smearing it using another slide, and immediately placing it in a 95 percent alcohol solution [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/44\">",
"     44",
"    </a>",
"    ]. Delay of even a few seconds may result in drying artifacts on the cells. The specimen is then flushed from the needle using 3 mL of saline or Hank's solution, and sent to the cytology lab for further processing.",
"   </p>",
"   <p>",
"    Specimens are sent for cell block preparation, which provides either cytologic or histologic examination, depending upon the size and integrity of the sample [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/35\">",
"     35",
"    </a>",
"    ]. When core specimens are desired, at least two satisfactory specimens should be obtained at each location, and multiple passes may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Tissue interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid on-site evaluation (ROSE) of the specimen by a cytopathologist for sample adequacy has been demonstrated to increase diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/46\">",
"     46",
"    </a>",
"    ]. Some of the criteria that may be used to judge the adequacy of a sample obtained for cytology are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef56119 \" href=\"UTD.htm?5/7/5243\">",
"     table 6",
"    </a>",
"    ). Specimens containing rare malignant cells rather than clumps of malignant cells should not be classified as malignant and should not be relied upon for definitive diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/47-50\">",
"     47-50",
"    </a>",
"    ]. The steps that may be taken to reduce false positive results and avoid overstaging of lung cancer are highlighted in the table (",
"    <a class=\"graphic graphic_table graphicRef76425 \" href=\"UTD.htm?12/63/13307\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Trained assistant",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trained assistant schooled in the intricacies of TBNA is essential to ensure smooth performance of the procedure and proper tissue handling, which are critical to achieving a high yield [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications following TBNA are uncommon if appropriate precautions are taken and the proper technique is employed. Although a variety of complications related to TBNA have been reported (",
"    <a class=\"graphic graphic_table graphicRef57265 \" href=\"UTD.htm?5/36/5707\">",
"     table 8",
"    </a>",
"    ), damage to the working channel of the bronchoscope is by far the most important. This complication is more common when nonretractable needles or 19 G needles are used, and great care needs to be taken while manipulating the apparatus through the bronchoscope [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/40,51,52\">",
"     40,51,52",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef81761 \" href=\"UTD.htm?24/30/25061\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The incidence of fever and bacteremia has been debated, and no firm recommendations can be made regarding antibiotic prophylaxis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .) Transient bacteremia six hours after the procedure with prompt defervescence after antibiotic therapy has been reported. After TBNA of a subcarinal mass, one patient experienced a purulent pericarditis with polymicrobial mouth flora and required pericardiocentesis and catheter drainage in addition to antibiotics to effect a cure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Marked bleeding has not been reported, even in anticoagulated patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Oozing of a minimal amount of blood from the puncture site may be encountered; the source is usually a dilated blood vessel in the tracheobronchial wall rather than invasion of a major mediastinal vascular structure. Although patients with superior vena caval obstruction are believed by some to be at increased risk of bleeding, a retrospective study of 27 patients reported no major bleeding complications and a high diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/59\">",
"     59",
"    </a>",
"    ]. The superior vena cava may actually be displaced anteriorly by enlarged paratracheal nodes, making inadvertent puncture less likely.",
"   </p>",
"   <p>",
"    Less frequent complications include pneumothorax, pneumomediastinum, and hemomediastinum [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/6,27,60,61\">",
"     6,27,60,61",
"    </a>",
"    ]. One patient with an elevated right hemidiaphragm underwent inadvertent liver biopsy but did not suffer any adverse clinical consequences [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MEDIASTINAL LYMPHADENOPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;TBNA has been most extensively employed in the diagnosis and staging of lung cancer, although the technique is also useful in a number of other settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Lung cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate staging of lung cancer with preoperative detection of mediastinal spread is critical to planning optimal treatment, including resection with curative intent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Lymph node enlargement on CT scan does not constitute proof of malignant spread. A meta-analysis of 42 studies examining the accuracy of CT in detecting mediastinal nodes infiltrated with malignancy reported a sensitivity and specificity of 79 and 78 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/63\">",
"     63",
"    </a>",
"    ]. A different study reported that 37 percent of mediastinal nodes measuring 2 to 4 cm were hyperplastic and contained no malignant foci [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/64\">",
"     64",
"    </a>",
"    ]. Thus, CT scanning is most useful for directing the biopsy of suspicious nodes but does not provide definitive staging information [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/30,65\">",
"     30,65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=see_link\">",
"     \"Diagnosis and staging of non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=see_link\">",
"     \"Tumor node metastasis (TNM) staging system for non-small cell lung cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=see_link\">",
"     \"Role of imaging in the staging of non-small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The options available for lymph node sampling include TBNA, cervical mediastinoscopy, and mediastinotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/66-68\">",
"     66-68",
"    </a>",
"    ]. Positive transcarinal aspirates have been used since the 1960s to assess resectability [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/17\">",
"     17",
"    </a>",
"    ]. Instances of patients with negative mediastinoscopy found later to develop subcarinal and pretracheal lymph node metastases can be avoided by TBNA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/25,69\">",
"     25,69",
"    </a>",
"    ]. This technique offers the ability to sample lymph nodes that are inaccessible to cervical mediastinoscopy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mediastinotomy on both sides of the tracheobronchial tree in one sitting. TBNA can also be performed in situations where mediastinoscopy is difficult or impossible, such as in patients with tracheostomy or those with severe cervical deformities.",
"   </p>",
"   <p>",
"    TBNA often establishes the diagnosis and provides staging information in a single procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/16,30,57\">",
"     16,30,57",
"    </a>",
"    ]. Demonstration by TBNA of N2 or N3 lymph nodes positive for non-small cell lung cancer avoids unnecessary surgical exploration for staging",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    resection, provides substantial cost savings, and reduces morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/29,31,35,70-72\">",
"     29,31,35,70-72",
"    </a>",
"    ]. TBNA is highly specific for the identification of mediastinal lymph node metastases, although the exact value depends on the prevalence in the population studied [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/72,73\">",
"     72,73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Predictors of positive TBNA in patients with suspected lung cancer include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of endoscopically visible endobronchial tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/30,74,75\">",
"       30,74,75",
"      </a>",
"      ], particularly involving the right upper lobe [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/76,77\">",
"       76,77",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Carinal involvement (visible tumor, widening, or erythema) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/16,30,31,74,75\">",
"       16,30,31,74,75",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Subcarinal lymph node size greater than 2 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/16,75\">",
"       16,75",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity of TBNA in diagnosing small cell carcinoma is higher than for non-small cell carcinoma and diagnosis of the former precludes surgical intervention in most cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/14,28,70,74,76\">",
"     14,28,70,74,76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=see_link\">",
"     \"First-line chemotherapy for patients with extensive stage small cell lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnostic yield of TBNA in the diagnosis and staging of lung cancer has been reported to range from 20 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/16,28,67,77-80\">",
"     16,28,67,77-80",
"    </a>",
"    ]. A meta-analysis of 13 studies found that the sensitivity and specificity of TBNA for the diagnosis of non-small cell lung cancer was 39 and 99 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/73\">",
"     73",
"    </a>",
"    ]. These values were dependent on the prevalence of lung cancer in the population. Even though the positive predictive value of TBNA approaches 100 percent in most published series, a negative result should prompt further testing, since the negative predictive value is low. Our recommendations regarding use of TBNA for the staging of lung cancer are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef57818 \" href=\"UTD.htm?20/21/20827\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Combined with another modality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Combining TBNA with other diagnostic modalities might increase the sensitivity of mediastinal analysis and reduce the need for surgical staging procedures [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/37,38,81-85\">",
"     37,38,81-85",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TBNA plus positron emission tomography (PET) &ndash; In an observational study of 113 patients with enlarged mediastinal lymph nodes, the sensitivity was higher among patients who underwent TBNA plus PET, compared to TBNA alone (100 versus 54 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      TBNA plus CT fluoroscopy &ndash; A trial randomly assigned 50 patients with suspected lung cancer to undergo CT fluoroscopy-guided TBNA or conventional TBNA [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/82\">",
"       82",
"      </a>",
"      ]. The sensitivity for detecting malignancy was higher among patients who underwent CT fluoroscopy-guided TBNA than conventional TBNA (100 versus 67 percent). This difference was not statistically significant but, if real, it would be clinically important. This suggests that larger studies are needed to exclude such a benefit.",
"     </li>",
"     <li>",
"      TBNA plus endobronchial ultrasound (EBUS) &ndash; The combined use of TBNA and EBUS can add to the diagnostic yield of TBNA in both malignant and non-malignant causes of mediastinal lymph node enlargement [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/85\">",
"       85",
"      </a>",
"      ]. EBUS and the related evidence are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=see_link\">",
"       \"Endobronchial ultrasound: Indications, advantages, and complications\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    TBNA has also been combined with CT-guidance. Further studies are required before any combination can be recommended as part of routine care. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12552?source=see_link\">",
"     \"Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Lymphoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical utility of TBNA in the diagnosis of lymphoma has been somewhat limited, since this usually requires larger samples of nodal tissue than are normally obtained by the 22 G needle. However, the availability of the 19 G histology needle, along with the use of flow cytometry to enhance diagnostic yield, may change this assumption [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/33,50,51,58,86\">",
"     33,50,51,58,86",
"    </a>",
"    ]. The diagnosis of lymphoma, using both cytology and histology needles, has been reported, although the yield of the procedure in this setting cannot be stated with certainty.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Sarcoidosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, patients suspected to have sarcoidosis with negative transbronchial lung biopsy were referred for mediastinoscopy. The availability of the 19 G histology needle makes TBNA a less invasive, safer, and more economical alternative for obtaining a pathologic diagnosis from mediastinal lymph nodes. TBNA is performed at the same time as transbronchial forceps biopsy in many centers.",
"   </p>",
"   <p>",
"    Several reports have confirmed an increase in the diagnostic yield when both transbronchial lung biopsies and TBNA are performed in patients with suspected sarcoidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/87-92\">",
"     87-92",
"    </a>",
"    ]. As an example, one study of 258 patients with suspected sarcoidosis found that the diagnostic yield increased from 66 to 78 percent when TBNA was added to transbronchial forceps biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/90\">",
"     90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of anecdotal reports of infection diagnosed via TBNA have appeared. TBNA has been involved in the diagnosis of histoplasmosis, Pneumocystis jirovecii pneumonia, and cryptococcal infection in patients with AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/34\">",
"     34",
"    </a>",
"    ]. In addition, the diagnosis of mediastinal mycobacterial adenitis (due to either Mycobacterium tuberculosis or M. avium-intracellulare) has been described in immunocompetent, as well as immunocompromised patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/34,93-101\">",
"     34,93-101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 1998 report highlights the usefulness of this technique in patients with HIV [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/102\">",
"     102",
"    </a>",
"    ]. Forty-one HIV-positive patients with intrathoracic adenopathy of unclear etiology underwent 44 TBNA (19 G) procedures, and 23 patients were demonstrated to have mycobacterial disease; aspirates showed smears positive for AFB in 11 (48 percent), 14 (61 percent) specimens grew mycobacteria, and caseous necrosis or necrotizing granulomatous lesions were seen in 15 (65 percent). In 11 of 23 procedures (48 percent), TBNA was the exclusive means of diagnosing mycobacterial disease. No major complications were reported. The report found TBNA to be less successful in patients with lymphoma and Kaposi's sarcoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Submucosal needle aspiration proximal to an endobronchial tumor to detect local spread may help predict the line of surgical resection in patients with non-small-cell carcinoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/103\">",
"     103",
"    </a>",
"    ]. Transbronchial needle aspiration has identified leiomyoma of the esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/34\">",
"     34",
"    </a>",
"    ], metastatic uterine rhabdomyosarcoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/104\">",
"     104",
"    </a>",
"    ], sclerosing hemangioma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/105\">",
"     105",
"    </a>",
"    ], and malignant pleural mesothelioma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/106\">",
"     106",
"    </a>",
"    ], while endobronchial aspirates have diagnosed both carcinoid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/107,108\">",
"     107,108",
"    </a>",
"    ] and malignant melanoma [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/109\">",
"     109",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mediastinal masses have been diagnosed and therapeutically aspirated using the transbronchial route [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/110-114\">",
"     110-114",
"    </a>",
"    ]. One report described a patient with a right paratracheal mass on CT scan that was suspicious for malignancy; TBNA revealed serosanguineous fluid suggestive of a sterile abscess, and there was no recurrence on later scans following aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/115\">",
"     115",
"    </a>",
"    ]. Decompression of a subcarinal cyst using TBNA permitted safe anesthesia and the subsequent resection of the cyst in another report [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/116\">",
"     116",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     AIRWAY LESIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to the high yield (67 to 100 percent) of forceps biopsy for diagnosing visible endobronchial lesions, the indications for TBNA are unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/76,117-122\">",
"     76,117-122",
"    </a>",
"    ]. However, TBNA has sometimes yielded the only diagnostic sample, and has a diagnostic yield between 65 and 87 percent when used alone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/10,14,117-123\">",
"     10,14,117-123",
"    </a>",
"    ]. Clinical situations in which TBNA of an endobronchial mass can be useful include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A visible lesion with surface necrosis which could lead to a negative forceps biopsy result (TBNA can help establish a diagnosis by obtaining samples from within the viable tumor mass)",
"     </li>",
"     <li>",
"      An endobronchial lesion which is likely to bleed, such as a carcinoid tumor [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/107,108\">",
"       107,108",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Suspected small cell carcinoma (extensive crush artifact on forceps biopsy specimens can decrease the diagnostic yield) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/124\">",
"       124",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Peribronchial and submucosal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The yield of conventional procedures such as forceps biopsy and brushing tends to be much lower in submucosal and peribronchial disease than for exophytic lesions because:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The abnormal lesion may be covered by normal epithelium, causing suboptimal sampling",
"     </li>",
"     <li>",
"      Submucosal infiltration by tumor may make tissues firmer, causing the forceps to slide off the lesion",
"     </li>",
"     <li>",
"      Peribronchial lesions are inaccessible to the biopsy forceps by virtue of being located outside the airway",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Under such circumstances, the addition of TBNA to obtain submucosal or peribronchial cytology samples could increase diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/9,10,14,125\">",
"     9,10,14,125",
"    </a>",
"    ]. One study of 31 patients with submucosal and peribronchial disease found that the sensitivity of biopsies obtained by forceps, TBNA, a combination of both forceps and TBNA, and a combination of forceps biopsy, bronchial brushing and washing, and TBNA was 55 percent, 71 percent, 89 percent, and 97 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PERIPHERAL NODULES OR MASSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transbronchial needle aspiration of peripheral nodules and masses using the 22 G cytology needle has emerged as an extremely useful diagnostic technique. Most studies indicate that the yield from TBNA is higher in peripheral lesions than from either forceps biopsy alone or a combination of conventional biopsy, brushing, and lavage procedures.",
"   </p>",
"   <p>",
"    Solitary pulmonary nodules (SPN) can be classified into four types according to the tumor-bronchus relationship (",
"    <a class=\"graphic graphic_figure graphicRef55148 \" href=\"UTD.htm?29/58/30624\">",
"     figure 8",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/126\">",
"     126",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The bronchial lumen is patent up to the tumor",
"     </li>",
"     <li>",
"      The bronchus is contained in the tumor mass",
"     </li>",
"     <li>",
"      The bronchus is compressed and narrowed by the tumor but the bronchial mucosa is intact",
"     </li>",
"     <li>",
"      The proximal tree is narrowed by peribronchial or submucosal spread of the tumor or by enlarged lymph nodes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    TBNA is particularly useful for increasing the diagnostic yield of flexible bronchoscopy in lesions in which the bronchus is compressed and narrowed by the tumor but the bronchial mucosa is intact, or in which the proximal bronchial tree is narrowed by peribronchial or submucosal spread of the tumor or by enlarged lymph nodes. In such situations, the submucosal or peribronchial location makes the tumor relatively inaccessible to other procedures such as washing, brushing, or transbronchial biopsy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=see_link\">",
"     \"Diagnostic evaluation and management of the solitary pulmonary nodule\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overall, 24 to 30 percent of peripheral lesions can be identified by TBNA exclusively. Lesion characteristics predicting an increased diagnostic yield in this setting include [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/8,123,127-129\">",
"     8,123,127-129",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Size greater than 2 cm (80 versus 33 to 58 percent)",
"     </li>",
"     <li>",
"      Concurrent mediastinal disease (89 versus 46 percent)",
"     </li>",
"     <li>",
"      The lesion is a hematogenous metastasis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The yield from a combination of TBNA plus forceps biopsy may be as high as 75 percent. Although the yield is lower than transthoracic needle aspiration (TTNA), there is a lower risk of pneumothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Combining TBNA with endobronchial ultrasound may increase the diagnostic yield of TBNA for peripheral lung nodules. A trial randomly assigned 293 patients with peripheral lung lesions to receive endobronchial ultrasound plus TBNA or TBNA alone [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/130\">",
"     130",
"    </a>",
"    ]. For patients with lung cancer, endobronchial ultrasound increased the sensitivity (0.79 versus 0.55) and accuracy (0.85 versus 0.69) of the diagnostic procedure. When the lesion was &lt;3 cm, there was a considerable decline in sensitivity and accuracy when TBNA was used alone, but not when TBNA was combined with endobronchial ultrasound.",
"   </p>",
"   <p>",
"    In contrast, CT fluoroscopy has not been shown to increase the diagnostic yield of TBNA for peripheral lung nodules. A trial that randomly assigned 50 patients with suspected lung cancer to undergo CT fluoroscopy-guided TBNA or conventional TBNA found no difference in the sensitivity of detecting malignancy in peripheral lesions (71 versus 76 percent for conventional TBNA) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/35/3642/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We believe that TBNA should be the procedure of choice for all nodules and masses except for a small subset of patients with lesions smaller than 2 cm, for whom TTNA may have a significant diagnostic advantage. When available, endobronchial ultrasound plus TBNA may also be useful for these smaller lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common application of TBNA is the diagnosis and staging of lung cancer. However, TBNA can also be used to sample mediastinal, hilar, endobronchial, submucosal, peribronchial (when extrinsic compression exists), or peripheral lesions (",
"      <a class=\"graphic graphic_table graphicRef57818 \" href=\"UTD.htm?20/21/20827\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Computed tomography (CT) is typically performed prior to bronchoscopy and TBNA in order to evaluate the relationship of the tracheobronchial tree to the surrounding structures, including lymph nodes and blood vessels. This maximizes diagnostic yield and safety. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Computed tomography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Smaller needles (eg, 20 to 22 gauge) are used to obtain cytology specimens, whereas larger needles (eg, 19 gauge) are necessary to obtain a core of tissue for histology. TBNA detects malignancy with greater sensitivity when a larger needle is used. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Type of needle'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A coagulation profile is not needed prior to TBNA in the absence of a history of bleeding diathesis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To perform TBNA, a needle-containing catheter is advanced through the flexible bronchoscope until the metal hub of the catheter is visible. The needle is then advanced from the tip of the catheter and locked into position. Next, the catheter is retracted until only the needle tip is visible. The bronchoscope is then advanced until the tip of the needle is anchored in its target, suction is applied, and the catheter is agitated (if no blood was aspirated). The needle-containing catheter is removed after suction is released. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of EBUS to increase the yield of TBNA in both malignant and non-malignant causes of mediastinal lymph node enlargement is an area of active research.",
"     </li>",
"     <li>",
"      Proper handling of the specimen is critical. The first specimen is sprayed from the needle onto a microscope slide using air, smeared using another slide, and then placed in 95 percent alcohol solution. Delays can result in drying artifacts. Subsequent specimens are flushed from the needle using saline or Hank's solution. On-site evaluation by a cytopathologist improves diagnostic yield. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Tissue preparation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/1\">",
"      Schieppati, E. La puncion mediastinal a traves del espolon traqueal. Rev As Med Argent 1949; 663:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/2\">",
"      BROUET G, PALEY PY, MARCHE J, LAVERGNE H. [Puncture for cytodiagnosis of peri-tracheo-bronchial isolated adenopathy]. J Fr Med Chir Thorac 1953; 7:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/3\">",
"      EULER HE, STRAUCH J, WITTE S. [Cytodiagnosis of mediastinal tumors]. Arch Ohren Nasen Kehlkopfheilkd 1955; 167:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/4\">",
"      SCHIEPPATI E. Mediastinal lymph node puncture through the tracheal carina. Surg Gynecol Obstet 1958; 107:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/5\">",
"      SCHIESSLE W. [Transbronchial and transtracheal puncture in peritracheobronchial adenopathies]. J Fr Med Chir Thorac 1962; 16:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/6\">",
"      Wang KP, Marsh BR, Summer WR, et al. Transbronchial needle aspiration for diagnosis of lung cancer. Chest 1981; 80:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/7\">",
"      Wang KP, Terry PB. Transbronchial needle aspiration in the diagnosis and staging of bronchogenic carcinoma. Am Rev Respir Dis 1983; 127:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/8\">",
"      Shure D, Fedullo PF. Transbronchial needle aspiration of peripheral masses. Am Rev Respir Dis 1983; 128:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/9\">",
"      Shure D, Fedullo PF. Transbronchial needle aspiration in the diagnosis of submucosal and peribronchial bronchogenic carcinoma. Chest 1985; 88:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/10\">",
"      Dasgupta A, Jain P, Minai OA, et al. Utility of transbronchial needle aspiration in the diagnosis of endobronchial lesions. Chest 1999; 115:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/11\">",
"      Hermens FH, Van Engelenburg TC, Visser FJ, et al. Diagnostic yield of transbronchial histology needle aspiration in patients with mediastinal lymph node enlargement. Respiration 2003; 70:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/12\">",
"      Sharafkhaneh A, Baaklini W, Gorin AB, Green L. Yield of transbronchial needle aspiration in diagnosis of mediastinal lesions. Chest 2003; 124:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/13\">",
"      Khoo KL, Chua GS, Mukhopadhyay A, Lim TK. Transbronchial needle aspiration: initial experience in routine diagnostic bronchoscopy. Respir Med 2003; 97:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/14\">",
"      Hsu LH, Liu CC, Ko JS. Education and experience improve the performance of transbronchial needle aspiration: a learning curve at a cancer center. Chest 2004; 125:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/15\">",
"      Ernst A, Silvestri GA, Johnstone D, American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest 2003; 123:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/16\">",
"      Bolliger CT, Mathur PN, Beamis JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 2002; 19:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/17\">",
"      VERSTEEGH RM, SWIERENGA J. BRONCHOSCOPIC EVALUATION OF THE OPERABILITY OF PULMONARY CARCINOMA. Acta Otolaryngol 1963; 56:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/18\">",
"      Rafanan AL, Mehta AC. Role of bronchoscopy in lung cancer. Semin Respir Crit Care Med 2000; 21:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/19\">",
"      Herth FJ, Rabe KF, Gasparini S, Annema JT. Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions. Eur Respir J 2006; 28:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/20\">",
"      Haponik EF, Shure D. Underutilization of transbronchial needle aspiration: experiences of current pulmonary fellows. Chest 1997; 112:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/21\">",
"      Pastis NJ, Nietert PJ, Silvestri GA, American College of Chest Physicians Interventional Chest/Diagnostic Procedures Network Steering Committee. Variation in training for interventional pulmonary procedures among US pulmonary/critical care fellowships: a survey of fellowship directors. Chest 2005; 127:1614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/22\">",
"      Chan, CC, Mehta, AC. Niche for the needle: TBNA and coagulopathy. J Bronchol 1996; 3:169.",
"     </a>",
"    </li>",
"    <li>",
"     Wang KP. Staging of bronchogenic carcinoma by bronchoscopy. In: Flexible Bronchoscopy, Wang KP, Mehta AC (Eds), Blackwell Science Inc, Cambridge, MA 1995. p.206.",
"    </li>",
"    <li>",
"     Kavuru MS, Mehta AC. Applied anatomy of the airways. In: Flexible Bronchoscopy, Wang KP, Mehta AC (Eds), Blackwell Science, Inc., Cambridge, MA 1995. p.6.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/25\">",
"      Carlens, E, Larsson, S. Mediastinoscopy in lung cancer. Semin Respir Med 1982; 3:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/26\">",
"      Patelli M, Lazzari Agli L, Poletti V, et al. Role of fiberscopic transbronchial needle aspiration in the staging of N2 disease due to non-small cell lung cancer. Ann Thorac Surg 2002; 73:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/27\">",
"      Wang KP, Brower R, Haponik EF, Siegelman S. Flexible transbronchial needle aspiration for staging of bronchogenic carcinoma. Chest 1983; 84:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/28\">",
"      Harrow EM, Abi-Saleh W, Blum J, et al. The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma. Am J Respir Crit Care Med 2000; 161:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/29\">",
"      Malenka DJ, Colice GL, Jacobs C, Beck JR. Mediastinal staging in non-small-cell lung cancer. Med Decis Making 1989; 9:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/30\">",
"      Utz JP, Patel AM, Edell ES. The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. Chest 1993; 104:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/31\">",
"      Shure D, Fedullo PF. The role of transcarinal needle aspiration in the staging of bronchogenic carcinoma. Chest 1984; 86:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/32\">",
"      Dasgupta, A, Mehta, AC, Wang, KP. Transbronchial needle aspiration. Sem Respir Crit Care Med 1997; 18:571.",
"     </a>",
"    </li>",
"    <li>",
"     Wang KP. Flexible bronchoscopy with transbronchial needle aspiration: Biopsy for cytology specimen. In: Biopsy Techniques in Pulmonary Disorders, 1989. p.63.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/34\">",
"      Wang, KP. Transbronchial needle aspiration to obtain histology specimen. J Bronchol 1994; 1:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/35\">",
"      Schenk DA, Chambers SL, Derdak S, et al. Comparison of the Wang 19-gauge and 22-gauge needles in the mediastinal staging of lung cancer. Am Rev Respir Dis 1993; 147:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/36\">",
"      Dasgupta A, Mehta AC. Transbronchial needle aspiration. An underused diagnostic technique. Clin Chest Med 1999; 20:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/37\">",
"      White CS, Weiner EA, Patel P, Britt EJ. Transbronchial needle aspiration: guidance with CT fluoroscopy. Chest 2000; 118:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/38\">",
"      Goldberg SN, Raptopoulos V, Boiselle PM, et al. Mediastinal lymphadenopathy: diagnostic yield of transbronchial mediastinal lymph node biopsy with CT fluoroscopic guidance-initial experience. Radiology 2000; 216:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/39\">",
"      Garpestad E, Goldberg S, Herth F, et al. CT fluoroscopy guidance for transbronchial needle aspiration: an experience in 35 patients. Chest 2001; 119:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/40\">",
"      Mehta AC, Curtis PS, Scalzitti ML, Meeker DP. The high price of bronchoscopy. Maintenance and repair of the flexible fiberoptic bronchoscope. Chest 1990; 98:448.",
"     </a>",
"    </li>",
"    <li>",
"     Minai OA, Dasgupta A, Mehta AC. Transbronchial needle aspiration of central and peripheral lesions. In: Progress in Respiratory Research-Interventional Bronchoscopy, Bolliger CT, Mathur PN (Eds), Karger, 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/42\">",
"      Chin R Jr, McCain TW, Lucia MA, et al. Transbronchial needle aspiration in diagnosing and staging lung cancer: how many aspirates are needed? Am J Respir Crit Care Med 2002; 166:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/43\">",
"      Diacon AH, Schuurmans MM, Theron J, et al. Transbronchial needle aspirates: how many passes per target site? Eur Respir J 2007; 29:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/44\">",
"      Wang KP, Selcuk ZT, Erozan Y. Transbronchial needle aspiration for cytology specimens. Monaldi Arch Chest Dis 1994; 49:265.",
"     </a>",
"    </li>",
"    <li>",
"     Mehta AC, Meeker DP. Transbronchial needle aspiration for histology speciments. In: Flexible Bronchoscopy, Wang KP, Mehta AC (Eds), Blackwell Science, Cambridge, MA 1995. p.199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/46\">",
"      Baram D, Garcia RB, Richman PS. Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration. Chest 2005; 128:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/47\">",
"      Baker JJ, Solanki PH, Schenk DA, et al. Transbronchial fine needle aspiration of the mediastinum. Importance of lymphocytes as an indicator of specimen adequacy. Acta Cytol 1990; 34:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/48\">",
"      Bhat N, Bhagat P, Pearlman ES, et al. Transbronchial needle aspiration biopsy in the diagnosis of pulmonary neoplasms. Diagn Cytopathol 1990; 6:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/49\">",
"      Horsley JR, Miller RE, Amy RW, King EG. Bronchial submucosal needle aspiration performed through the fiberoptic bronchoscope. Acta Cytol 1984; 28:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/50\">",
"      Wagner ED, Ramzy I, Greenberg SD, Gonzalez JM. Transbronchial fine-needle aspiration. Reliability and limitations. Am J Clin Pathol 1989; 92:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/51\">",
"      Wang KP, Haponik EF, Gupta PK, Erozan YS. Flexible transbronchial needle aspiration. Technical considerations. Ann Otol Rhinol Laryngol 1984; 93:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/52\">",
"      Sherling BE. Complication with a transbronchial histology needle. Chest 1990; 98:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/53\">",
"      Mehta AC, Minai OA. Infection control in the bronchoscopy suite. A review. Clin Chest Med 1999; 20:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/54\">",
"      Watts WJ, Green RA. Bacteremia following transbronchial fine needle aspiration. Chest 1984; 85:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/55\">",
"      Witte MC, Opal SM, Gilbert JG, et al. Incidence of fever and bacteremia following transbronchial needle aspiration. Chest 1986; 89:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/56\">",
"      Epstein SK, Winslow CJ, Brecher SM, Faling LJ. Polymicrobial bacterial pericarditis after transbronchial needle aspiration. Case report with an investigation on the risk of bacterial contamination during fiberoptic bronchoscopy. Am Rev Respir Dis 1992; 146:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/57\">",
"      Harrow EM, Oldenburg FA Jr, Lingenfelter MS, Smith AM Jr. Transbronchial needle aspiration in clinical practice. A five-year experience. Chest 1989; 96:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/58\">",
"      Wang KP, Britt EJ, Haponik EF, et al. Rigid transbronchial needle aspiration biopsy for histological specimens. Ann Otol Rhinol Laryngol 1985; 94:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/59\">",
"      Sel&ccedil;uk ZT, Firat P. The diagnostic yield of transbronchial needle aspiration in superior vena cava syndrome. Lung Cancer 2003; 42:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/60\">",
"      Gasparini S, Ferretti M, Secchi EB, et al. Integration of transbronchial and percutaneous approach in the diagnosis of peripheral pulmonary nodules or masses. Experience with 1,027 consecutive cases. Chest 1995; 108:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/61\">",
"      Kucera RF, Wolfe GK, Perry ME. Hemomediastinum after transbronchial needle aspiration. Chest 1986; 90:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/62\">",
"      Mehta, AC, Kathawalla, SA, Fischler, D, Demeter, SL. Bronchoscopic liver biopsy. J Bronchol 1994; 1:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/63\">",
"      Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer. Approaching a controversy using meta-analysis. Am Rev Respir Dis 1990; 141:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/64\">",
"      McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/65\">",
"      Schenk DA, Bower JH, Bryan CL, et al. Transbronchial needle aspiration staging of bronchogenic carcinoma. Am Rev Respir Dis 1986; 134:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/66\">",
"      Kramer H, Groen HJ. Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer. Ann Surg 2003; 238:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/67\">",
"      Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123:157S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/68\">",
"      Mazzone P, Jain P, Arroliga AC, Matthay RA. Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 2002; 23:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/69\">",
"      Hashim SW, Baue AE, Geha AS. The role of mediastinoscopy and mediastinotomy in lung cancer. Clin Chest Med 1982; 3:353.",
"     </a>",
"    </li>",
"    <li>",
"     Harrow EM, Oldenburg FA, Lingenfelter MS, Smith AM. Transbronchial needle aspiration in clinical practice. In: Flexible Bronchoscopy, Wang KP, Mehta AC (Eds), Blackwell Science, Cambridge, MA 1995. p.222.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/71\">",
"      Jain, P, Arroliga, A, Mehta, AC. Cost-effectiveness of transbronchial needle aspiration in the staging of lung cancer. Chest 1996; 110:S24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/72\">",
"      Patel NM, Pohlman A, Husain A, et al. Conventional transbronchial needle aspiration decreases the rate of surgical sampling of intrathoracic lymphadenopathy. Chest 2007; 131:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/73\">",
"      Holty JE, Kuschner WG, Gould MK. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax 2005; 60:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/74\">",
"      Harrow E, Halber M, Hardy S, Halteman W. Bronchoscopic and roentgenographic correlates of a positive transbronchial needle aspiration in the staging of lung cancer. Chest 1991; 100:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/75\">",
"      Haponik EF, Cappellari JO, Chin R, et al. Education and experience improve transbronchial needle aspiration performance. Am J Respir Crit Care Med 1995; 151:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/76\">",
"      Schenk DA, Bryan CL, Bower JH, Myers DL. Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma. Chest 1987; 92:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/77\">",
"      Cetinkaya E, Yildiz P, Altin S, Yilmaz V. Diagnostic value of transbronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest 2004; 125:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/78\">",
"      Cetinkaya E, Yildiz P, Kadakal F, et al. Transbronchial needle aspiration in the diagnosis of intrathoracic lymphadenopathy. Respiration 2002; 69:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/79\">",
"      Xie HB, Cornwell R, Grossman JE, et al. Bronchoscopy-guided transtracheal and transbronchial fine-needle aspiration biopsy: a 5-year institutional review of 111 cases. Diagn Cytopathol 2002; 27:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/80\">",
"      Bila&ccedil;ero��lu S, Ca��iotariotaciota U, G&uuml;nel O, et al. Comparison of rigid and flexible transbronchial needle aspiration in the staging of bronchogenic carcinoma. Respiration 1998; 65:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/81\">",
"      Bernasconi M, Chhajed PN, Gambazzi F, et al. Combined transbronchial needle aspiration and positron emission tomography for mediastinal staging of NSCLC. Eur Respir J 2006; 27:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/82\">",
"      Ost D, Shah R, Anasco E, et al. A randomized trial of CT fluoroscopic-guided bronchoscopy vs conventional bronchoscopy in patients with suspected lung cancer. Chest 2008; 134:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/83\">",
"      Herth F, Becker HD, Ernst A. Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 2004; 125:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/84\">",
"      Herth FJ, Becker HD, Ernst A. Ultrasound-guided transbronchial needle aspiration: an experience in 242 patients. Chest 2003; 123:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/85\">",
"      Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006; 61:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/86\">",
"      Ketai L, Chauncey J, Duque R. Combination of flow cytometry and transbronchial needle aspiration in the diagnosis of mediastinal lymphoma. Chest 1985; 88:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/87\">",
"      Trisolini R, Lazzari Agli L, Cancellieri A, et al. The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest 2003; 124:2126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/88\">",
"      Bila&ccedil;ero��lu S, Perim K, G&uuml;nel O, et al. Combining transbronchial aspiration with endobronchial and transbronchial biopsy in sarcoidosis. Monaldi Arch Chest Dis 1999; 54:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/89\">",
"      Leonard C, Tormey VJ, O'Keane C, Burke CM. Bronchoscopic diagnosis of sarcoidosis. Eur Respir J 1997; 10:2722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/90\">",
"      Pauli G, Pelletier A, Bohner C, et al. Transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 1984; 85:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/91\">",
"      Wang KP, Fuenning C, Johns CJ, Terry PB. Flexible transbronchial needle aspiration for the diagnosis of sarcoidosis. Ann Otol Rhinol Laryngol 1989; 98:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/92\">",
"      Morales CF, Patefield AJ, Strollo PJ Jr, Schenk DA. Flexible transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 1994; 106:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/93\">",
"      Jain P, Sandur S, Meli Y, et al. Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 2004; 125:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/94\">",
"      Malabonga VM, Basti J, Kamholz SL. Utility of bronchoscopic sampling techniques for cryptococcal disease in AIDS. Chest 1991; 99:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/95\">",
"      Baran R, Tor M, Tahao��lu K, et al. Intrathoracic tuberculous lymphadenopathy: clinical and bronchoscopic features in 17 adults without parenchymal lesions. Thorax 1996; 51:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/96\">",
"      Baron KM, Aranda CP. Diagnosis of mediastinal mycobacterial lymphadenopathy by transbronchial needle aspiration. Chest 1991; 100:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/97\">",
"      Calpe JL, Chiner E, Larramendi CH. Endobronchial tuberculosis in HIV-infected patients. AIDS 1995; 9:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/98\">",
"      Pastores SM, Naidich DP, Aranda CP, et al. Intrathoracic adenopathy associated with pulmonary tuberculosis in patients with human immunodeficiency virus infection. Chest 1993; 103:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/99\">",
"      Juli&agrave; Serd&agrave; G, Rodriguez de Castro F, Fernandez S&aacute;nchez-Alarcos JM, et al. Transcarinal needle aspiration in the diagnosis of mediastinal adenitis in a patient infected with the human immunodeficiency virus. Thorax 1990; 45:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/100\">",
"      Simecek C. Diagnosis of mycobacterial mediastinal lymphadenopathy by transbronchial needle aspiration. Chest 1992; 102:1919.",
"     </a>",
"    </li>",
"    <li>",
"     Wang KP, Harrow EM. Transbronchial needle aspiration: A decade of experience. In: Textbook of Bronchoscopy, Feinsilver SH, Fein AM (Eds), 1995. p.85.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/102\">",
"      Harkin TJ, Ciotoli C, Addrizzo-Harris DJ, et al. Transbronchial needle aspiration (TBNA) in patients infected with HIV. Am J Respir Crit Care Med 1998; 157:1913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/103\">",
"      York EL, Jones RL, King EG, et al. The value of submucous needle aspiration in the prediction of surgical resection line of bronchogenic carcinoma. Chest 1991; 100:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/104\">",
"      Goldstein LS, Kavuru MS, Meli Y, et al. Uterine rhabdomyosarcoma metastatic to mediastinal lymph nodes: diagnosis by transbronchial needle aspiration. South Med J 1999; 92:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/105\">",
"      Hirano H, Miyagawa Y, Nagata N, et al. Transbronchial needle aspiration in the diagnosis of pulmonary sclerosing haemangioma. Respir Med 1993; 87:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/106\">",
"      Selcuk, ZT, Hafiz, MA, Wang, KP. Malignant pleural mesothelioma diagnosed by transbronchial needle biopsy. J Bronchol 1997; 4:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/107\">",
"      Conley YD, Cafoncelli AR, Khan JH, et al. Bronchial carcinoid tumor: experience over 20 years. Am Surg 1992; 58:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/108\">",
"      Givens CD Jr, Marini JJ. Transbronchial needle aspiration of a bronchial carcinoid tumor. Chest 1985; 88:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/109\">",
"      Das, RK, Dasgupta, A, Tewari, S, Mehta, AC. Malignant melanoma of the bronchus. J Bronchol 1998; 5:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/110\">",
"      Barz&oacute; P. Transbronchial mediastinal cystography. Chest 1988; 93:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/111\">",
"      Kuhlman JE, Fishman EK, Wang KP, et al. Mediastinal cysts: diagnosis by CT and needle aspiration. AJR Am J Roentgenol 1988; 150:75.",
"     </a>",
"    </li>",
"    <li>",
"     Scatarige JC, Wang KP, Siegelman SS. Transbronchial needle aspiration biopsy of the mediastinum. In: Contemporary Issues in Computed Tomography: Computed Tomography of the Chest, Siegelman SS (Ed), Churchill Livingstone, New York 1984. p.59.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/113\">",
"      Schwartz AR, Fishman EK, Wang KP. Diagnosis and treatment of a bronchogenic cyst using transbronchial needle aspiration. Thorax 1986; 41:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/114\">",
"      Schwartz DB, Beals TF, Wimbish KJ, Hammersley JR. Transbronchial fine needle aspiration of bronchogenic cysts. Chest 1985; 88:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/115\">",
"      Wang KP, Nelson S, Scatarige J, Siegelman S. Transbronchial needle aspiration of a mediastinal mass: therapeutic implications. Thorax 1983; 38:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/116\">",
"      McDougall JC, Fromme GA. Transcarinal aspiration of a mediastinal cyst to facilitate anesthetic management. Chest 1990; 97:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/117\">",
"      Buirski G, Calverley PM, Douglas NJ, et al. Bronchial needle aspiration in the diagnosis of bronchial carcinoma. Thorax 1981; 36:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/118\">",
"      Lundgren R, Bergman F, Angstr&ouml;m T. Comparison of transbronchial fine needle aspiration biopsy, aspiration of bronchial secretion, bronchial washing, brush biopsy and forceps biopsy in the diagnosis of lung cancer. Eur J Respir Dis 1983; 64:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/119\">",
"      Kvale PA, Bode FR, Kini S. Diagnostic accuracy in lung cancer; comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest 1976; 69:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/120\">",
"      Popovich J Jr, Kvale PA, Eichenhorn MS, et al. Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis 1982; 125:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/121\">",
"      Shure D, Astarita RW. Bronchogenic carcinoma presenting as an endobronchial mass. Chest 1983; 83:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/122\">",
"      Zavala DC. Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients. Chest 1975; 68:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/123\">",
"      Castella J, Buj J, Puzo C, et al. Diagnosis and staging of bronchogenic carcinoma by transtracheal and transbronchial needle aspiration. Ann Oncol 1995; 6 Suppl 3:S21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/124\">",
"      Jones DF, Chin R Jr, Cappellari JO, Haponik EF. Endobronchial needle aspiration in the diagnosis of small-cell carcinoma. Chest 1994; 105:1151.",
"     </a>",
"    </li>",
"    <li>",
"     Mehta AC, Meeker DP. Transbronchial needle aspiration for histology specimens. In: Flexible Bronchoscopy, Wang KP, Mehta AC (Eds), Blackwell Science, Cambridge, MA 1995. p.199.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/126\">",
"      Tsuboi E, Ikeda S, Tajima M, et al. Transbronchial biopsy smear for diagnosis of peripheral pulmonary carcinomas. Cancer 1967; 20:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/127\">",
"      Wang, KP, Gonullu, U, Baker, R. Transbronchial needle aspiration versus transthoracic needle aspiration in the diagnosis of pulmonary lesions. J Bronchol 1994; 1:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/128\">",
"      Katis K, Inglesos E, Zachariadis E, et al. The role of transbronchial needle aspiration in the diagnosis of peripheral lung masses or nodules. Eur Respir J 1995; 8:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/129\">",
"      Wang KP, Haponik EF, Britt EJ, et al. Transbronchial needle aspiration of peripheral pulmonary nodules. Chest 1984; 86:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/35/3642/abstract/130\">",
"      Paone G, Nicastri E, Lucantoni G, et al. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions. Chest 2005; 128:3551.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4383 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-04C97D187A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3642=[""].join("\n");
var outline_f3_35_3642=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TECHNICAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Type of needle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Tissue preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Tissue interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Trained assistant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MEDIASTINAL LYMPHADENOPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Lung cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Combined with another modality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Lymphoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      AIRWAY LESIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Peribronchial and submucosal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PERIPHERAL NODULES OR MASSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4383\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4383|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/28/19914\" title=\"figure 1\">",
"      IASLC lymph node map",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?5/39/5759\" title=\"figure 2A\">",
"      Position of subcarinal nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/58/8098\" title=\"figure 2B\">",
"      Position of R paratracheal node",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/47/35569\" title=\"figure 2C\">",
"      Position of L paratracheal node",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/58/22432\" title=\"figure 3\">",
"      Angle of bronchial puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/1/11295\" title=\"figure 4A\">",
"      Jabbing method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/50/2863\" title=\"figure 4B\">",
"      Piggyback method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/15/1279\" title=\"figure 4C\">",
"      Cough method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/40/32399\" title=\"figure 5\">",
"      Insertion of needle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/5/27729\" title=\"figure 6\">",
"      Retrieval of histology specimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/30/25061\" title=\"figure 7\">",
"      Retracted TBNA needle position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/58/30624\" title=\"figure 8\">",
"      Tumor bronchus relationships",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4383|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/21/20827\" title=\"table 1\">",
"      Indications for TBNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/28/2507\" title=\"table 2\">",
"      Six Ts of TBNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/40/652\" title=\"table 3\">",
"      Approach to mediastinal nodes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/10/13483\" title=\"table 4\">",
"      Recommendations routine TBNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/21/37211\" title=\"table 5\">",
"      Bronchial wall puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/7/5243\" title=\"table 6\">",
"      Criteria for adequate specimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/63/13307\" title=\"table 7\">",
"      Avoiding false positive TBNA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/36/5707\" title=\"table 8\">",
"      Complications of TBNA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/31/14841?source=related_link\">",
"      Diagnosis and staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/31/44537?source=related_link\">",
"      Diagnostic evaluation and management of the solitary pulmonary nodule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/32/19976?source=related_link\">",
"      Endobronchial ultrasound: Indications, advantages, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/16/12552?source=related_link\">",
"      Endoscopic ultrasound-guided fine-needle aspiration in the mediastinum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/39/6778?source=related_link\">",
"      First-line chemotherapy for patients with extensive stage small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/10/19625?source=related_link\">",
"      Role of imaging in the staging of non-small cell lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/21/44373?source=related_link\">",
"      Tumor node metastasis (TNM) staging system for non-small cell lung cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_35_3643="Extrapancreatic manif AIP";
var content_f3_35_3643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58707&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Extrapancreatic manifestations of autoimmune pancreatitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Inflammatory bowel disease (primarily ulcerative colitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IgG4-associated cholangitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung nodules, adenopathy, infiltrates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sj&ouml;gren's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Retroperitoneal fibrosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bile duct strictures, especially long strictures without beading",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tubulointerstitial nephritis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune thyroiditis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3643=[""].join("\n");
var outline_f3_35_3643=null;
var title_f3_35_3644="CBTRUS ped hist dist";
var content_f3_35_3644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F67876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F67876&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=11\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Distribution of primary brain and CNS tumors by histology in children younger than 15 years",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Type",
"      </td>",
"      <td class=\"subtitle1\">",
"       Number",
"      </td>",
"      <td class=\"subtitle1\">",
"       Percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pilocytic astrocytoma",
"      </td>",
"      <td>",
"       958",
"      </td>",
"      <td>",
"       19.3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glioma malignant, NOS",
"      </td>",
"      <td>",
"       668",
"      </td>",
"      <td>",
"       13.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Embryonal/primitive/medulloblastoma",
"      </td>",
"      <td>",
"       654",
"      </td>",
"      <td>",
"       13.2",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Other astrocytoma",
"      </td>",
"      <td>",
"       318",
"      </td>",
"      <td>",
"       9.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ependymoma/anaplastic ependymoma",
"      </td>",
"      <td>",
"       294",
"      </td>",
"      <td>",
"       5.9",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nerve sheath",
"      </td>",
"      <td>",
"       216",
"      </td>",
"      <td>",
"       4.4",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Germ cell",
"      </td>",
"      <td>",
"       185",
"      </td>",
"      <td>",
"       3.7",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Craniopharyngioma",
"      </td>",
"      <td>",
"       179",
"      </td>",
"      <td>",
"       3.6",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pituitary",
"      </td>",
"      <td>",
"       146",
"      </td>",
"      <td>",
"       2.9",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glioblastoma",
"      </td>",
"      <td>",
"       125",
"      </td>",
"      <td>",
"       2.5",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Total",
"       </strong>",
"      </td>",
"      <td>",
"       <strong>",
"        4959",
"       </strong>",
"      </td>",
"      <td>",
"       <strong>",
"        100",
"       </strong>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    CBTRUS Statistical Report: NPCR and SEER Data from 2004-2005.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: CBTRUS (2009) Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2005. Central Brain Tumor Registry of the United States, Hinsdale, IL.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3644=[""].join("\n");
var outline_f3_35_3644=null;
var title_f3_35_3645="Age at onset RPC";
var content_f3_35_3645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78633&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Age at onset of relapsing polychondritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 339px; height: 230px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The age at onset compiled from 572 patients with relapsing polychondritis. The majority of cases occur between the ages of 40 and 60.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3645=[""].join("\n");
var outline_f3_35_3645=null;
var title_f3_35_3646="Carboplatin plus docetaxel for adv non-small cell lung cancer";
var content_f3_35_3646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Carboplatin plus docetaxel for advanced non-small cell lung cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: Every 21 days, for a maximum of six cycles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Carboplatin",
"        </strong>",
"       </td>",
"       <td>",
"        AUC* = 6 mg/mL x min IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL normal saline (NS)",
"        <sup>",
"         &Delta;",
"        </sup>",
"        and administer over 30 minutes. Carboplatin should be administered after the completion of docetaxel infusion.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Docetaxel",
"        </strong>",
"       </td>",
"       <td>",
"        75 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL NS",
"        <sup>",
"         &Delta;",
"        </sup>",
"        to a final concentration of 0.3 to 0.74 mg/mL and administer over 60 minutes. Docetaxel should be infused prior to carboplatin.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        MODERATE. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Premedicate with dexamethasone prior to docetaxel administration",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Carboplatin and docetaxel are irritants, but can cause significant tissue damage; avoid extravasation. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with hematopoietic growth factors is not recommended (incidence of febrile neutropenia approximately 4 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        ). Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Each carboplatin dose should be calculated based upon renal function by use of the Calvert formula*. Docetaxel should not be administered to patients with a serum bilirubin above the ULN or to patients with transaminase elevations &gt;1.5 x ULN in conjunction with alkaline phosphatase &gt;2.5 x ULN. Refer to UpToDate topics on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\" and \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential and platelet count prior to each cycle of treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Electrolytes and liver and renal function prior to each cycle of treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        The US FDA-approved product labeling recommends reducing the dose of carboplatin by 25 percent if platelets are &lt;50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and/or ANC is &lt;500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        <sup>",
"         [3]",
"        </sup>",
"        . Docetaxel should only be administered if the ANC is greater than 1500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        . A 25 percent dose reduction of docetaxel is recommended for subsequent cycles in patients who develop severe prolonged neutropenia (less than 500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        lasting seven days or more), febrile neutropenia, or a grade 4 infection (ie, an infection with life-threatening consequences)",
"        <sup>",
"         [2]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Nonhematologic toxicity:",
"        </strong>",
"        No formal dosing recommendations were reported in the final publication",
"        <sup>",
"         [1]",
"        </sup>",
"        . However, dose reductions for each agent may be needed for serious nonhematologic toxicity. Refer to UpToDate topic on \"Carboplatin: Drug information\" and \"Docetaxel: Drug information\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cutaneous, mucosal, and neurologic toxicity:",
"        </strong>",
"        For severe or cumulative cutaneous reactions (erythema and desquamation), grade 3 or 4 stomatitis, or moderate neurosensory signs and/or symptoms, the dose of docetaxel should be reduced from 75 to 60 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        <sup>",
"         [2]",
"        </sup>",
"        . If toxicity persists, treatment should be discontinued.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; ULN: upper limit of normal; CBC: complete blood count; ANC: absolute neutrophil count; GFR: glomerular filtration rate.",
"     <br/>",
"     * AUC (area under the concentration X time curve) is converted to a patient-specific carboplatin dose (in mg) according to renal function by using the Calvert formula. The Calvert formula is total dose (mg) = (target AUC) x (GFR + 25). If using measured serum creatinine, limit the maximal GFR for the calculation to 125 mL/min. Refer to UpToDate topic on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"     <br/>",
"     &Delta; Diluent solutions should not be modified without consulting a detailed reference due to potential incompatibility(ies).",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Fossella F, et al. J Clin Oncol 2003; 21:3016.",
"      </li>",
"      <li>",
"       Taxotere (docetaxel) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 15, 2011).",
"      </li>",
"      <li>",
"       Carboplatin injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 15, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3646=[""].join("\n");
var outline_f3_35_3646=null;
var title_f3_35_3647="Screening implications";
var content_f3_35_3647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    HLA-B*5701 screening implications",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 328px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The main benefit of screening, regardless of race, is that it identifies the majority of the population to whom it is safe to administer abacavir. Although screening necessarily excludes some patients from abacavir therapy who would have tolerated the drug, this is compensated by the fall in false positive clinical diagnoses achieved in an open screening population.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_35_3647=[""].join("\n");
var outline_f3_35_3647=null;
